<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="3.0" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="nlm-ta">PLoS Comput Biol</journal-id>
<journal-id journal-id-type="pmc">ploscomp</journal-id><journal-title-group>
<journal-title>PLoS Computational Biology</journal-title></journal-title-group>
<issn pub-type="ppub">1553-734X</issn>
<issn pub-type="epub">1553-7358</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, USA</publisher-loc></publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">PCOMPBIOL-D-12-01894</article-id>
<article-id pub-id-type="doi">10.1371/journal.pcbi.1003102</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biology</subject><subj-group><subject>Computational biology</subject></subj-group><subj-group><subject>Immunology</subject></subj-group></subj-group></article-categories>
<title-group>
<article-title>Models of Self-Peptide Sampling by Developing T Cells Identify Candidate Mechanisms of Thymic Selection</article-title>
<alt-title alt-title-type="running-head">Modeling Thymic Selection</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Bains</surname><given-names>Iren</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>van Santen</surname><given-names>Hisse M.</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Seddon</surname><given-names>Benedict</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Yates</surname><given-names>Andrew J.</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff4"><sup>4</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib>
</contrib-group>
<aff id="aff1"><label>1</label><addr-line>Immune Cell Biology, MRC National Institute for Medical Research, Mill Hill, London, United Kingdom</addr-line></aff>
<aff id="aff2"><label>2</label><addr-line>Department of Systems and Computational Biology, Albert Einstein College of Medicine, New York, New York, United States of America</addr-line></aff>
<aff id="aff3"><label>3</label><addr-line>Centro Biologia Molecular Severo Ochoa, CSIC/Universidad Autonoma de Madrid, Madrid, Spain</addr-line></aff>
<aff id="aff4"><label>4</label><addr-line>Department of Microbiology and Immunology, Albert Einstein College of Medicine, New York, New York, United States of America</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple"><name name-style="western"><surname>Chakraborty</surname><given-names>Arup K.</given-names></name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"/></contrib>
</contrib-group>
<aff id="edit1"><addr-line>Massachusetts Institute of Technology, United States of America</addr-line></aff>
<author-notes>
<corresp id="cor1">* E-mail: <email xlink:type="simple">andrew.yates@einstein.yu.edu</email></corresp>
<fn fn-type="conflict"><p>The authors have declared that no competing interests exist.</p></fn>
<fn fn-type="con"><p>Conceived and designed the study: IB AJY. Contributed data: HMvS. Performed analysis and modelling of data: IB AJY. Wrote the paper: IB HMvS BS AJY.</p></fn>
</author-notes>
<pub-date pub-type="collection"><month>7</month><year>2013</year></pub-date>
<pub-date pub-type="epub"><day>25</day><month>7</month><year>2013</year></pub-date>
<volume>9</volume>
<issue>7</issue>
<elocation-id>e1003102</elocation-id>
<history>
<date date-type="received"><day>30</day><month>11</month><year>2012</year></date>
<date date-type="accepted"><day>1</day><month>5</month><year>2013</year></date>
</history>
<permissions>
<copyright-year>2013</copyright-year>
<copyright-holder>Bains et al</copyright-holder><license xlink:type="simple"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions>
<abstract>
<p>Conventional and regulatory T cells develop in the thymus where they are exposed to samples of self-peptide MHC (pMHC) ligands. This probabilistic process selects for cells within a range of responsiveness that allows the detection of foreign antigen without excessive responses to self. Regulatory T cells are thought to lie at the higher end of the spectrum of acceptable self-reactivity and play a crucial role in the control of autoimmunity and tolerance to innocuous antigens. While many studies have elucidated key elements influencing lineage commitment, we still lack a full understanding of how thymocytes integrate signals obtained by sampling self-peptides to make fate decisions. To address this problem, we apply stochastic models of signal integration by T cells to data from a study quantifying the development of the two lineages using controllable levels of agonist peptide in the thymus. We find two models are able to explain the observations; one in which T cells continually re-assess fate decisions on the basis of multiple summed proximal signals from TCR-pMHC interactions; and another in which TCR sensitivity is modulated over time, such that contact with the same pMHC ligand may lead to divergent outcomes at different stages of development. Neither model requires that T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e001" xlink:type="simple"/></inline-formula> and T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e002" xlink:type="simple"/></inline-formula> are differentially susceptible to deletion or that the two lineages need qualitatively different signals for development, as have been proposed. We find additional support for the variable-sensitivity model, which is able to explain apparently paradoxical observations regarding the effect of partial and strong agonists on T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e003" xlink:type="simple"/></inline-formula> and T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e004" xlink:type="simple"/></inline-formula> development.</p>
</abstract>
<abstract abstract-type="summary"><title>Author Summary</title>
<p>T cells develop in the thymus, where they are vetted â€“ they must respond weakly to self-antigens, but not so strongly as to risk causing autoimmunity. This selection process involves developing T cells being exposed to a large sample of self-peptides presented on specialised cells in the thymus, and deciding to die or to differentiate into mature T cells of either conventional or regulatory lineages. The rules by which T cells assimilate information from these interactions to make these decisions are not known. In this study we use previously published data to assess and discriminate between different models of thymic selection and find the most support for a model in which T cells vary their sensitivity to self-peptides during their development. This allows fate decisions to be made on the basis of as few as one peptide at a time, which allows for fine specificity in the selection process.</p>
</abstract>
<funding-group><funding-statement>Funded by the NIH (R01AI093870 to AJY), the MRC (U117573801 to BS), and the Ministerio de Economia y Competitividad (BFU2009-08009 to HMvS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><page-count count="16"/></counts></article-meta>
</front>
<body><sec id="s1">
<title>Introduction</title>
<p>Conventional <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e005" xlink:type="simple"/></inline-formula> T cells (T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e006" xlink:type="simple"/></inline-formula>) and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e007" xlink:type="simple"/></inline-formula> T regulatory cells (T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e008" xlink:type="simple"/></inline-formula>) are essential components of the adaptive immune system. Conventional T cells develop effector function in response to foreign antigens, while natural T regulatory cells produced in the thymus play a key role in the maintenance of tolerance to self-antigens and prevent autoimmune diseases (reviewed in, for example, <xref ref-type="bibr" rid="pcbi.1003102-Wing1">[1]</xref>). Both populations are derived from precursors in the thymus that develop, undergo selection and differentiate into different T cell lineages. The differentiation of a thymocyte into the mature <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e009" xlink:type="simple"/></inline-formula> T cell repertoire is dependent on the engagement of its T cell receptor (TCR) with endogenous peptides presented by major histocompatibility complex (MHC) molecules on thymic antigen presenting cells. Continued very weak or null interactions between the TCR and peptide-MHC ligands (pMHC) lead to failure to positively select (â€˜death by neglectâ€™) while excessively strong TCR-pMHC interactions lead to negative selection, removing highly autoreactive cells from the T cell repertoire. However, the precise rules underlying T cell precursor fate are not well understood; based on its exposure to a sample of pMHC, how and when does a thymocyte decide to become a T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e010" xlink:type="simple"/></inline-formula>, a T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e011" xlink:type="simple"/></inline-formula>, or be deleted?</p>
<p>Studies using fetal thymic organ cultures have shown that there exists a sharp avidity threshold between positive and negatively selecting ligands <xref ref-type="bibr" rid="pcbi.1003102-Williams1">[2]</xref>, <xref ref-type="bibr" rid="pcbi.1003102-Daniels1">[3]</xref>. There is substantial evidence indicating that T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e012" xlink:type="simple"/></inline-formula> are induced by TCR signals that lie below this negative selection threshold, but above that required for selection into the conventional T cell pool <xref ref-type="bibr" rid="pcbi.1003102-Maloy1">[4]</xref>â€“<xref ref-type="bibr" rid="pcbi.1003102-Wong1">[8]</xref>. However, many uncertainties remain. It has been shown that expression of cognate antigen (which we loosely refer to â€˜agonist peptideâ€™) in the thymic epithelium is required for the generation of T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e013" xlink:type="simple"/></inline-formula> <xref ref-type="bibr" rid="pcbi.1003102-Jordan1">[9]</xref>â€“<xref ref-type="bibr" rid="pcbi.1003102-Larkin1">[13]</xref>, but a recent study showed that T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e014" xlink:type="simple"/></inline-formula> commitment occurs over a wide range of TCR affinities for a ubiquitously expressed self antigen <xref ref-type="bibr" rid="pcbi.1003102-Lee1">[14]</xref>. Further, the partitioning of fates with increasing strength of recognition for self (deletion<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e015" xlink:type="simple"/></inline-formula>T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e016" xlink:type="simple"/></inline-formula><inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e017" xlink:type="simple"/></inline-formula>T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e018" xlink:type="simple"/></inline-formula><inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e019" xlink:type="simple"/></inline-formula>deletion) appears to be questioned by a study in which both expression of an agonist and a weaker partial-agonist could enhance deletion, but only the agonist was able to induce the formation of <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e020" xlink:type="simple"/></inline-formula> regulatory T cells <xref ref-type="bibr" rid="pcbi.1003102-CozzoPicca1">[15]</xref>, suggesting that either the mapping of avidity to fate is more complex or that qualitatively different signals are required for T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e021" xlink:type="simple"/></inline-formula> and T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e022" xlink:type="simple"/></inline-formula> selection.</p>
<p>Many experimental models using TCR transgenic cells (clonal populations of T cells with identical TCR) have shown that these cells can develop into both the regulatory and conventional lineages together in the same environment. This observation implies that there is stochasticity in fate determination. This stochasticity can be partitioned conceptually into two sources that are not mutually exclusive. First, there may be heterogeneity at the early double positive <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e023" xlink:type="simple"/></inline-formula> stage of development, even within a clonal population, that pre-disposes cells to different fates. This heterogeneity might derive, for example, from differences in expression of factors determining the baseline levels or dynamic range of TCR signalling, or other signalling proteins related to lineage commitment. Second, stochasticity may be present later in the selection process, arising at least in part because each thymocyte encounters an independent sample of self-peptide ligands. Evidence for the latter comes from observations that probabilities of deletion and T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e024" xlink:type="simple"/></inline-formula> generation have been shown to vary with levels of agonist-peptide expression; <italic>in-vivo</italic> studies in TCR transgenic mice <xref ref-type="bibr" rid="pcbi.1003102-vanSanten1">[16]</xref>â€“<xref ref-type="bibr" rid="pcbi.1003102-Atibalentja1">[18]</xref> and <italic>in-vitro</italic> fetal thymic organ culture <xref ref-type="bibr" rid="pcbi.1003102-Sebzda1">[19]</xref>â€“<xref ref-type="bibr" rid="pcbi.1003102-Feuerer1">[21]</xref> have shown that the efficiency of T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e025" xlink:type="simple"/></inline-formula> selection increases with modest increases in agonist-peptide expression, but drops when expression is high. (We use the term <italic>efficiency</italic> here interchangeably with the probability of experiencing a given fate.) The efficiency of selection into the T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e026" xlink:type="simple"/></inline-formula> lineage also decreases in the presence of increasing numbers of cells of the same specificity <xref ref-type="bibr" rid="pcbi.1003102-Lee1">[14]</xref>, <xref ref-type="bibr" rid="pcbi.1003102-CozzoPicca1">[15]</xref>, <xref ref-type="bibr" rid="pcbi.1003102-Bautista1">[22]</xref>â€“<xref ref-type="bibr" rid="pcbi.1003102-Moran1">[24]</xref>. Thus the availability of relevant ligands, either in absolute terms or through competition, can influence fate decisions.</p>
<p>The timing of an interaction with a ligand may also influence fate. There is evidence that the sensitivity of thymocytes to TCR stimulation is increased during maturation through the subcellular localisation of signalling molecules such as tyrosine kinase Lck <xref ref-type="bibr" rid="pcbi.1003102-Eck1">[25]</xref>; the inhibition of extracellular signal-regulated kinase (ERK) activation and increased expression of inhibitory tyrosine phosphatase SHP-1 <xref ref-type="bibr" rid="pcbi.1003102-Stephen1">[26]</xref>; the upregulation of the negative regulator CD5 <xref ref-type="bibr" rid="pcbi.1003102-Azzam1">[27]</xref>; and the increased expression of ZAP-70, a downstream target of TCR signalling <xref ref-type="bibr" rid="pcbi.1003102-Saini1">[28]</xref>. However, the expression of miR-181a, a microRNA that enhances sensitivity to TCR stimulation, is reduced during thymic development <xref ref-type="bibr" rid="pcbi.1003102-Neilson1">[29]</xref>, <xref ref-type="bibr" rid="pcbi.1003102-Li1">[30]</xref>, and TCR signalling in response to low-affinity pMHC ligands is strongest in immature thymocytes <xref ref-type="bibr" rid="pcbi.1003102-Davey1">[31]</xref>. The net effect of changes in TCR signal activating and inhibiting factors is not clear, but it is possible that stimulation with the same ligand will lead to different levels of activation in the same thymocyte at different stages of development.</p>
<p>The challenge of synthesising these observations and describing quantitatively how the affinity, number and timing of pMHC contacts shape the developing T cell repertoire invites a mathematical modelling approach. Models of thymic selection have been successful in providing insight into the relationship between diversity of self peptides sampled in the thymus and the cross-reactivity <xref ref-type="bibr" rid="pcbi.1003102-Chao1">[32]</xref>, <xref ref-type="bibr" rid="pcbi.1003102-Kosmrlj1">[33]</xref>, alloreactivity <xref ref-type="bibr" rid="pcbi.1003102-Detours1">[34]</xref>, size <xref ref-type="bibr" rid="pcbi.1003102-Detours2">[35]</xref>, <xref ref-type="bibr" rid="pcbi.1003102-Faro1">[36]</xref> and CD4SP/CD8SP ratio <xref ref-type="bibr" rid="pcbi.1003102-SouzaeSilva1">[37]</xref> of the selected repertoire. Models have also helped us understand the relation of HLA phenotype to viral epitope recognition <xref ref-type="bibr" rid="pcbi.1003102-Kosmrlj2">[38]</xref> and the trade-off between MHC and T cell receptor diversity <xref ref-type="bibr" rid="pcbi.1003102-Borghans1">[39]</xref>. In this study we use stochastic (probabilistic) models to describe previously published <italic>in vivo</italic> data describing T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e027" xlink:type="simple"/></inline-formula> and T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e028" xlink:type="simple"/></inline-formula> commitment of a transgenic cell population in the presence of varying densities of agonist peptide in the thymus <xref ref-type="bibr" rid="pcbi.1003102-vanSanten1">[16]</xref>. These data allow us to test and discriminate between models of how developing thymocytes might integrate signals received from pMHC ligands to make lineage decisions.</p>
<p>Models of thymic selection must relate the physical interaction between a TCR and a pMHC ligand to the signal interpreted or integrated by the thymocyte. There is evidence to support competing models of TCR-pMHC interactions in which the level of T cell activation is determined by TCR-pMHC dwell times, through the kinetic proofreading model <xref ref-type="bibr" rid="pcbi.1003102-McKeithan1">[40]</xref>, <xref ref-type="bibr" rid="pcbi.1003102-Germain1">[41]</xref>, TCR occupancy <xref ref-type="bibr" rid="pcbi.1003102-Valitutti1">[42]</xref>â€“<xref ref-type="bibr" rid="pcbi.1003102-Labrecque1">[44]</xref> and overall pMHC ligand affinity <xref ref-type="bibr" rid="pcbi.1003102-Stone1">[45]</xref>. Previous approaches to quantitative modelling of TCR-pMHC interactions can be divided into three broad categories: (i) detailed modelling of signal transduction immediately downstream of TCR-pMHC engagement <xref ref-type="bibr" rid="pcbi.1003102-Prasad1">[46]</xref>, <xref ref-type="bibr" rid="pcbi.1003102-AltanBonnet1">[47]</xref>; (ii) kinetic models of binding events using measured rates of TCR-pMHC association and disassociation <xref ref-type="bibr" rid="pcbi.1003102-Currie1">[48]</xref>, <xref ref-type="bibr" rid="pcbi.1003102-Govern1">[49]</xref>; and (iii) the use of a â€˜string modelâ€™ framework in which the strength of an interaction is determined by pairwise interaction energies between peptides and the aligned residues of amino acids on the variable CDR3 loop of randomly generated TCRs <xref ref-type="bibr" rid="pcbi.1003102-Chao1">[32]</xref>, <xref ref-type="bibr" rid="pcbi.1003102-Kosmrlj1">[33]</xref>. However, binding kinetic parameters are not available for the full range of endogenous peptides that are encountered during thymic development, and uncertainty remains in the relation between avidity and the signalling thresholds determining fate decisions. Here, we abstract from the mechanistic model of signal strength derived from molecular interactions. Instead we assume a distribution of signal strengths that a given TCR derives from pMHC ligands, in which low-strength signalling events occur with the greatest likelihood and, in line with our knowledge of the specificity of T cell recognition, stronger signalling events occur with decreasing probability. We show that our conclusions are insensitive to the precise form of this distribution.</p>
<p>We explore candidate mechanisms of T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e029" xlink:type="simple"/></inline-formula> and T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e030" xlink:type="simple"/></inline-formula> selection using the canonical hypothesis that signals associated with T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e031" xlink:type="simple"/></inline-formula> commitment are stronger than those required for T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e032" xlink:type="simple"/></inline-formula> commitment but are below the threshold for negative selection. We use the data of van Santen <italic>et al.</italic> <xref ref-type="bibr" rid="pcbi.1003102-vanSanten1">[16]</xref> to reject a simple model of the selection process in which thymocyte fate is based on testing sequential single TCR-pMHC interactions. Instead, we find the data can be explained with two generalisations of this model in which perceived TCR signal strength correlates to a strict hierarchy of cell fates (neglect<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e033" xlink:type="simple"/></inline-formula>T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e034" xlink:type="simple"/></inline-formula><inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e035" xlink:type="simple"/></inline-formula>T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e036" xlink:type="simple"/></inline-formula><inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e037" xlink:type="simple"/></inline-formula> negative selection). In both models, thymocytes are continuously initiating fate decisions based on measuring the strength of binding to self peptide-MHC ligands in a series of encounters with antigen-presenting cells. In one class of model, the <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e038" xlink:type="simple"/></inline-formula> model, cells measure the avidity of each encounter, each of which comprises binding to a sample of multiple self-peptide-MHC ligands simultaneously. The <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e039" xlink:type="simple"/></inline-formula> model is motivated by studies implicating the integration of signals from multiple pMHC interactions in the priming of mature T cells by antigen <xref ref-type="bibr" rid="pcbi.1003102-Underhill1">[50]</xref>â€“<xref ref-type="bibr" rid="pcbi.1003102-Mempel1">[53]</xref>. In the second class of model, the two-phase model, we examine the consequences of TCR sensitivity of thymocytes varying during development. In this model a cell's interpretation of the signal derived from a given ligand depends on whether it occurs early or late in selection. We show that both models are able to describe the data, and also make predictions that are consistent with studies quantifying the efficiency of T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e040" xlink:type="simple"/></inline-formula> selection with avidity <xref ref-type="bibr" rid="pcbi.1003102-Lee1">[14]</xref>. However, we argue that variable TCR sensitivity is required to explain the effect of partial and full agonist peptide expression in the thymus on T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e041" xlink:type="simple"/></inline-formula> generation and negative selection reported by Cozzo Picca and colleagues <xref ref-type="bibr" rid="pcbi.1003102-CozzoPicca1">[15]</xref>.</p>
</sec><sec id="s2" sec-type="methods">
<title>Methods</title>
<sec id="s2a">
<title>Experimental data</title>
<p>We use data from van Santen <italic>et al.</italic> (2004) <xref ref-type="bibr" rid="pcbi.1003102-vanSanten1">[16]</xref> in which the frequency of high affinity intra-thymic ligands was manipulated <italic>in vivo</italic>. Briefly, a mouse line was used that employs the tetracycline inducible system to conditionally express an invariant chain mutant, bearing the T cell epitope from moth cytochrome <italic>c</italic> (MCC) in place of the class-II associated invariant chain peptide (CLIP)-encoding region (TIM). TIM was expressed in both cortical and medullary thymic epithelial cells (cTEC and mTEC), and at controllable and graded levels. The mice also contained a transgene encoding a TCR specific for this peptide, such that in the absence of induced TIM, these cells differentiated efficiently into mature <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e042" xlink:type="simple"/></inline-formula> CD4 single positive thymocytes. Expression of TIM, measured by TIM RNA transcripts via real-time PCR, influenced both T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e043" xlink:type="simple"/></inline-formula> and T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e044" xlink:type="simple"/></inline-formula> formation in a non-linear fashion (<xref ref-type="fig" rid="pcbi-1003102-g001">Figure 1</xref>).</p>
<fig id="pcbi-1003102-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1003102.g001</object-id><label>Figure 1</label><caption>
<title>Data taken from van Santen <italic>et al.</italic> <xref ref-type="bibr" rid="pcbi.1003102-vanSanten1">[16]</xref>.</title>
<p>Absolute number of clonotype positive <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e045" xlink:type="simple"/></inline-formula> (T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e046" xlink:type="simple"/></inline-formula>, red circles) and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e047" xlink:type="simple"/></inline-formula> (T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e048" xlink:type="simple"/></inline-formula>, blue circles) thymocytes in tetracycline-treated TAND mice, as a function of the relative expression level of TIM RNA in the thymus of these animals. Control animals lacked either the transactivator or reporter transgene.</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1003102.g001" position="float" xlink:type="simple"/></fig>
<p>In <xref ref-type="fig" rid="pcbi-1003102-g001">Figure 1</xref> we see that (i) low frequencies of a strong agonist (TIM) do not affect the selection of TCR-specific (AND) thymocytes into the conventional T cell pool; (ii) moderate increases in agonist expression lead to increasing efficiency of selection of AND cells into T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e049" xlink:type="simple"/></inline-formula> (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e050" xlink:type="simple"/></inline-formula>(T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e051" xlink:type="simple"/></inline-formula>) against <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e052" xlink:type="simple"/></inline-formula>(Relative TIM RNA) between <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e053" xlink:type="simple"/></inline-formula>; Pearson correlation <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e054" xlink:type="simple"/></inline-formula>) and a concurrent drop in the efficiency of T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e055" xlink:type="simple"/></inline-formula> selection; and (iii) high frequencies of a strong agonist lead to the deletion of AND T cells. A very similar trend was observed by Cozzo Picca <italic>et al.</italic> <xref ref-type="bibr" rid="pcbi.1003102-CozzoPicca2">[17]</xref> using TCR transgenic cells specific for an epitope of influenza virus in the presence of different levels of expression of this agonist. Atibalentja <italic>et al.</italic> <xref ref-type="bibr" rid="pcbi.1003102-Atibalentja1">[18]</xref> also observed this trend following intravenous injection of varying concentrations of hen egg-white lysozyme (HEL), which was rapidly processed and presented in the thymus, resulting in the negative selection of specific TCR transgenic T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e056" xlink:type="simple"/></inline-formula> and an increase in TCR transgenic T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e057" xlink:type="simple"/></inline-formula> at low, but loss at higher, HEL concentrations.</p>
</sec><sec id="s2b">
<title>Mathematical models</title>
<p>Developing thymocytes survey pMHC ligands presented on the surface of thymic epithelial cells. In all models we assume that fate decisions are continually reassessed based on â€˜encountersâ€™, each of which is the sum of <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e058" xlink:type="simple"/></inline-formula> interactions with pMHC (<xref ref-type="fig" rid="pcbi-1003102-g002">Figure 2</xref>), where <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e059" xlink:type="simple"/></inline-formula>. Each thymocyte participates in <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e060" xlink:type="simple"/></inline-formula> encounters at most, where a thymocyte might undergo negative selection, or initiate development into the T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e061" xlink:type="simple"/></inline-formula> or T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e062" xlink:type="simple"/></inline-formula> lineages, before reaching its <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e063" xlink:type="simple"/></inline-formula>-th encounter. We assume that each encounter with one or more pMHC can be divided into four categories determined by its affinity or avidity and the resulting signal through the T cell receptor(s). These are (i) a weak or null signal below that required for positive selection; (ii) a signal sufficient for selection into the T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e064" xlink:type="simple"/></inline-formula> lineage; (iii) a signal that initiates selection into the T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e065" xlink:type="simple"/></inline-formula> lineage; and (iv) a strong signal that leads to deletion.</p>
<fig id="pcbi-1003102-g002" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1003102.g002</object-id><label>Figure 2</label><caption>
<title>Thymocyte encounters with self-peptides.</title>
<p>An <italic>encounter</italic> is defined as the simultaneous or temporally proximal binding of <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e066" xlink:type="simple"/></inline-formula> TCR to <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e067" xlink:type="simple"/></inline-formula> pMHC ligands on a thymic epithelial cell. Here, <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e068" xlink:type="simple"/></inline-formula>.</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1003102.g002" position="float" xlink:type="simple"/></fig>
<p>We considered two classes of models. In one, the distribution of signal strengths resulting from encounters is constant throughout the selection period - the <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e069" xlink:type="simple"/></inline-formula> model. In the other, the two-phase model, we allow for the possibility that this distribution shifts during selection as a result of temporal changes in TCR sensitivity.</p>
<sec id="s2b1">
<title>Fate decisions made by integrating TCR signals; the <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e070" xlink:type="simple"/></inline-formula> model</title>
<p>The <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e071" xlink:type="simple"/></inline-formula> interactions constituting an encounter may occur simultaneously, or sequentially within a time interval that is short compared to the decay time for TCR signals transduced by binding to pMHC. We consider an encounter to be the unit of information that can influence fate decisions. When one TCR binds to one randomly chosen pMHC, the contact results in a signal of strength drawn from an unknown probability distribution. One correlate of â€˜strengthâ€™ might be the affinity of binding. Indeed affinity of binding to selecting pMHC ligands has been demonstrated to be linearly proportional to selection efficiency <xref ref-type="bibr" rid="pcbi.1003102-Lee1">[14]</xref>. Similarly, when signals from multiple, proximal TCR-pMHC binding events are integrated in each encounter (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e072" xlink:type="simple"/></inline-formula>), the resulting signal strength might be related to the avidity of the interaction. However we allow freedom in the interpretation of the term <italic>strength</italic> to allow for non-linear relationships between the off-rate of a TCR-pMHC complex and the signal transduced by the TCR. It is simply the quantity resulting from each encounter that the T cell uses in its fate-determination machinery. We assume a log-normal distribution of signal strengths, for reasons we discuss below.</p>
<p>To illustrate the calculation of selection efficiencies in this model, consider the case <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e073" xlink:type="simple"/></inline-formula> (<xref ref-type="fig" rid="pcbi-1003102-g003">Figure 3A</xref>). Selection into the conventional T cell lineage requires:</p>
<fig id="pcbi-1003102-g003" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1003102.g003</object-id><label>Figure 3</label><caption>
<title>The influence of TIM expression on the distribution of signal strengths resulting from thymocyte encounters.</title>
<p><bold>A</bold>: The case <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e074" xlink:type="simple"/></inline-formula>. The probabilities <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e075" xlink:type="simple"/></inline-formula>) are those of a signal lying within the different selecting regions. Blue curve; log-normally distributed signal strengths <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e076" xlink:type="simple"/></inline-formula> from self pMHC in the absence of TIM expression. Area under the curveâ€Š=â€Š1. Red curve; TIM expressed at frequency <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e077" xlink:type="simple"/></inline-formula> superimposed on this wild-type (endogenous pMHC) distribution. The spike at <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e078" xlink:type="simple"/></inline-formula> (shown for convenience here with finite width and height) is a point mass in the probability distribution, of area <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e079" xlink:type="simple"/></inline-formula>; the remainder is of area <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e080" xlink:type="simple"/></inline-formula>. <bold>B</bold>: For <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e081" xlink:type="simple"/></inline-formula> the different selecting regions lie beween different signal strength thresholds <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e082" xlink:type="simple"/></inline-formula>. Increasing TIM expression <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e083" xlink:type="simple"/></inline-formula> (the proportion of pMHC within an encounter, on average) shifts the distribution of signal strengths rightwards.</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1003102.g003" position="float" xlink:type="simple"/></fig>
<list list-type="order"><list-item>
<p>at least one encounter with strength greater than a positive selection threshold, <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e084" xlink:type="simple"/></inline-formula>;</p>
</list-item><list-item>
<p>all <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e085" xlink:type="simple"/></inline-formula> encounters below a higher threshold <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e086" xlink:type="simple"/></inline-formula>.</p>
</list-item></list>
<p>Experimental evidence suggests that T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e087" xlink:type="simple"/></inline-formula> development requires agonist peptide to be presented in the thymus <xref ref-type="bibr" rid="pcbi.1003102-Jordan1">[9]</xref>, <xref ref-type="bibr" rid="pcbi.1003102-Apostolou1">[10]</xref>, <xref ref-type="bibr" rid="pcbi.1003102-Aschenbrenner1">[12]</xref>, <xref ref-type="bibr" rid="pcbi.1003102-Moran1">[24]</xref>, <xref ref-type="bibr" rid="pcbi.1003102-Kawahata2">[54]</xref>. The canonical explanation is that T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e088" xlink:type="simple"/></inline-formula> are induced by TCR signals that lie below the threshold of negative selection, but above that required for selection into the conventional T cell pool. So we define a negative selection threshold <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e089" xlink:type="simple"/></inline-formula>, above <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e090" xlink:type="simple"/></inline-formula>, such that an encounter between <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e091" xlink:type="simple"/></inline-formula> triggers divergence into the T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e092" xlink:type="simple"/></inline-formula> lineage. For T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e093" xlink:type="simple"/></inline-formula> selection, then,</p>
<list list-type="order"><list-item>
<p>at least one of the <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e094" xlink:type="simple"/></inline-formula> encounters is above a positive selection threshold, <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e095" xlink:type="simple"/></inline-formula> (to pass positive selection),</p>
</list-item><list-item>
<p>all <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e096" xlink:type="simple"/></inline-formula> encounters are below the threshold <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e097" xlink:type="simple"/></inline-formula> (to avoid negative selection),</p>
</list-item><list-item>
<p>at least one encounter occurs between thresholds <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e098" xlink:type="simple"/></inline-formula>.</p>
</list-item></list>
<p>While this model does not contain time explicitly, the <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e099" xlink:type="simple"/></inline-formula> encounters are considered to occur sequentially and so negative selection (deletion) can be initiated at any time by an encounter with strength <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e100" xlink:type="simple"/></inline-formula>. This also means that it is possible, for example, for a cell to receive a signal within the T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e101" xlink:type="simple"/></inline-formula> region and initiate development into that lineage, but later to have an encounter above <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e102" xlink:type="simple"/></inline-formula> and be deleted. It also means than <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e103" xlink:type="simple"/></inline-formula> is an upper limit on the number of thymocyte encounters; the mean number of encounters will be fewer than <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e104" xlink:type="simple"/></inline-formula> due to early termination through negative selection.</p>
<p>We then calculate the probability of each fate (fail positive selection, T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e105" xlink:type="simple"/></inline-formula>, T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e106" xlink:type="simple"/></inline-formula>, deletion) after <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e107" xlink:type="simple"/></inline-formula> encounters. These depend simply on the probabilities <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e108" xlink:type="simple"/></inline-formula> of an encounter falling in each region (<xref ref-type="fig" rid="pcbi-1003102-g003">Figure 3A</xref>, blue curve);<disp-formula id="pcbi.1003102.e109"><graphic position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1003102.e109" xlink:type="simple"/><label>(1)</label></disp-formula><disp-formula id="pcbi.1003102.e110"><graphic position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1003102.e110" xlink:type="simple"/><label>(2)</label></disp-formula></p>
<p>Now assume a proportion <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e111" xlink:type="simple"/></inline-formula> of endogenous peptides are replaced by the agonist peptide TIM. Each TCR-pMHC contact will involve an endogenous peptide with probability <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e112" xlink:type="simple"/></inline-formula> or TIM with probability <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e113" xlink:type="simple"/></inline-formula>. The signal strength derived from this contact will respectively be lognormally-distributed or with fixed strength <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e114" xlink:type="simple"/></inline-formula>. Agonist ligands appear to induce deletion as well as T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e115" xlink:type="simple"/></inline-formula> commitment <xref ref-type="bibr" rid="pcbi.1003102-Jordan1">[9]</xref>â€“<xref ref-type="bibr" rid="pcbi.1003102-Larkin1">[13]</xref>, <xref ref-type="bibr" rid="pcbi.1003102-vanSanten1">[16]</xref> and so it is likely that <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e116" xlink:type="simple"/></inline-formula> lies above <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e117" xlink:type="simple"/></inline-formula>. To illustrate, assume it lies within the window that triggers T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e118" xlink:type="simple"/></inline-formula> commitment, the region bounded by <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e119" xlink:type="simple"/></inline-formula>. At expression level <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e120" xlink:type="simple"/></inline-formula>, the probabilities <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e121" xlink:type="simple"/></inline-formula> change as follows (<xref ref-type="fig" rid="pcbi-1003102-g003">Figure 3A</xref>, red curve):<disp-formula id="pcbi.1003102.e122"><graphic position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1003102.e122" xlink:type="simple"/><label>(3)</label></disp-formula>For any <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e123" xlink:type="simple"/></inline-formula>, the probability of selection into T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e124" xlink:type="simple"/></inline-formula> is<disp-formula id="pcbi.1003102.e125"><graphic position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1003102.e125" xlink:type="simple"/><label>(4)</label></disp-formula>and the probability of selection into T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e126" xlink:type="simple"/></inline-formula> is<disp-formula id="pcbi.1003102.e127"><graphic position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1003102.e127" xlink:type="simple"/><label>(5)</label></disp-formula>which is a function of the maximum number of encounters <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e128" xlink:type="simple"/></inline-formula> but is independent of the selection thresholds or the probabilities <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e129" xlink:type="simple"/></inline-formula>.</p>
<p>When <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e130" xlink:type="simple"/></inline-formula>, we assume each encounter is of strength <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e131" xlink:type="simple"/></inline-formula>. The <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e132" xlink:type="simple"/></inline-formula> are identically distributed random variables representing the strength of a single TCR-pMHC binding. Each binding generates either (i) a signal arising from a randomly selected endogenous pMHC, with probability <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e133" xlink:type="simple"/></inline-formula>, or (ii) a signal of strength <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e134" xlink:type="simple"/></inline-formula> resulting from an interaction with TIM pMHC with probability <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e135" xlink:type="simple"/></inline-formula>. We denote the selection thresholds as <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e136" xlink:type="simple"/></inline-formula>. When <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e137" xlink:type="simple"/></inline-formula> is small, the distribution of signal strengths contains point masses at <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e138" xlink:type="simple"/></inline-formula>, 2 <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e139" xlink:type="simple"/></inline-formula>, and so on. As <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e140" xlink:type="simple"/></inline-formula> increases, the distribution becomes smoother and shifts rightwards with increasing <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e141" xlink:type="simple"/></inline-formula> (<xref ref-type="fig" rid="pcbi-1003102-g003">Figure 3B</xref>). <xref ref-type="supplementary-material" rid="pcbi.1003102.s005">Text S1</xref> contains the calculation of the selection probabilities for <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e142" xlink:type="simple"/></inline-formula>.</p>
<p>Given the complexities of TCR signalling, individual TCR binding events may not contribute linearly to an encounter's strength, however â€˜strengthâ€™ is defined. However for our arguments all we require is (i) that endogeneous pMHC provide a smooth distribution of signal strengths arising from encounters, (ii) when agonist is present at frequency <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e143" xlink:type="simple"/></inline-formula>, this distribution shifts rightwards, and (iii) the more pMHC involved in an encounter, the smoother this perturbed distribution is. The additive model is a minimal model that gives this biologically reasonable behaviour.</p>
</sec><sec id="s2b2">
<title>Variable TCR sensitivity: The two-phase model</title>
<p>This model is an extension of the one-hit (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e144" xlink:type="simple"/></inline-formula>) model that also allows the sensitivity of immature thymocytes to TCR stimulation to vary during maturation. For simplicity, the selection process is divided into two distinct phases, A and B, each with maximum number of interactions <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e145" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e146" xlink:type="simple"/></inline-formula>. In each phase the TCR-pMHC encounters are divided into distinct selecting categories, as before, with probabilities <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e147" xlink:type="simple"/></inline-formula> in the A-phase, where <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e148" xlink:type="simple"/></inline-formula>, and probabilities <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e149" xlink:type="simple"/></inline-formula> in the B-phase (<xref ref-type="fig" rid="pcbi-1003102-g004">Figure 4</xref>).</p>
<fig id="pcbi-1003102-g004" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1003102.g004</object-id><label>Figure 4</label><caption>
<title>The two-phase model.</title>
<p>In this instance, TCR sensitivity is assumed to increase during development, such that an encounter with the agonist ligand TIM delivers a signal that initiates T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e150" xlink:type="simple"/></inline-formula> development early in selection (phase A) but causes deletion if encountered later (phase B).</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1003102.g004" position="float" xlink:type="simple"/></fig>
<p>As above, we assume that a thymocyte participates in <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e151" xlink:type="simple"/></inline-formula> encounters at most. At any time during development a signal above the positive selection threshold <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e152" xlink:type="simple"/></inline-formula> triggers T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e153" xlink:type="simple"/></inline-formula> development; this decision can be superceded by a signal above the threshold <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e154" xlink:type="simple"/></inline-formula> which triggers differentiation into the T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e155" xlink:type="simple"/></inline-formula> lineage; and a thymocyte can be negatively selected at any time by a signal greater than <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e156" xlink:type="simple"/></inline-formula>.</p>
<p>The predictions of the model are independent of the order of the phases A and B. Here we discuss the situation in which TCR sensitivity increases during thymic development. In this scenario, <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e157" xlink:type="simple"/></inline-formula> initially lies within the T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e158" xlink:type="simple"/></inline-formula>-selecting region, meaning that an encounter with agonist in phase A initiates T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e159" xlink:type="simple"/></inline-formula> commitment and causes deletion in phase B (<xref ref-type="fig" rid="pcbi-1003102-g003">Figure 3</xref>). The changes in the quantities <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e160" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e161" xlink:type="simple"/></inline-formula> with TIM expression <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e162" xlink:type="simple"/></inline-formula> follow the form of <xref ref-type="disp-formula" rid="pcbi.1003102.e122">equation 3</xref>, and we then express the probabilities of selection into each lineage as a function of <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e163" xlink:type="simple"/></inline-formula> and the parameters <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e164" xlink:type="simple"/></inline-formula>. Details are in <xref ref-type="supplementary-material" rid="pcbi.1003102.s006">Text S2</xref>.</p>
</sec><sec id="s2b3">
<title>The choice of the distribution of signal strengths</title>
<p>In both models, a thymocyte's fate is determined by the maximum signal strength experienced over a large number of encounters. We assume the strength of a single TCR-pMHC binding is log-normally distributed. The strength of an encounter (the sum of <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e165" xlink:type="simple"/></inline-formula> proximal TCR-pMHC interactions) is then also approximately log-normally distributed <xref ref-type="bibr" rid="pcbi.1003102-Nadarajah1">[55]</xref>. We choose the log-normal distribution because it is ubiquitous in cell biology, and arises naturally when a random variable is derived from multiplying random variables from arbitrary distributions â€“ such as concentrations of different signalling molecules in signal transduction pathways. However the maximum value of a large sample drawn from any heavy-tailed distribution converges to the same (FrÃ©chet) distribution <xref ref-type="bibr" rid="pcbi.1003102-Fisher1">[56]</xref>, <xref ref-type="bibr" rid="pcbi.1003102-Gnedenko1">[57]</xref>. Each thymocyte is indeed expected to participate in a large number of encounters, and so our results hold for any heavy-tailed distribution of TCR-pMHC interaction strengths. Further, relative, not absolute, values of these signal strengths are key to the modelling of fate decisions and so we can set the mean of this distribution to be 1. The variance of the distribution is a free parameter which also does not influence our conclusions, but we discuss its influence on some parameter estimates in the <xref ref-type="sec" rid="s3">Results</xref>.</p>
</sec><sec id="s2b4">
<title>Relating absolute peptide abundance to relative RNA expression</title>
<p>We model agonist abundance <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e166" xlink:type="simple"/></inline-formula> as the fraction of endogenous peptides replaced by the agonist peptide, while the measure of agonist abundance used in ref. <xref ref-type="bibr" rid="pcbi.1003102-vanSanten1">[16]</xref> is the relative expression of TIM RNA compared to that in control thymi. The relationship between <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e167" xlink:type="simple"/></inline-formula> and TIM RNA is unknown, although we would expect it to increase monotonically. Further, a saturating level of TIM RNA is unlikely to achieve exclusive TIM expression (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e168" xlink:type="simple"/></inline-formula>), either due to competition for loading onto MHC from endogenous peptides and/or the presence of dendritic cells in the thymus that express endogenous but not TIM peptide MHC complexes. In the absence of more information we assume a sigmoid linear-log relation that is approximately linear at low TIM expression levels and saturates at <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e169" xlink:type="simple"/></inline-formula>,<disp-formula id="pcbi.1003102.e170"><graphic position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1003102.e170" xlink:type="simple"/><label>(6)</label></disp-formula>where [RNA] is the TIM RNA expression level relative to controls and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e171" xlink:type="simple"/></inline-formula> is the expression level at which <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e172" xlink:type="simple"/></inline-formula> is half-maximum. <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e173" xlink:type="simple"/></inline-formula> is a measure of the steepness of the function around <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e174" xlink:type="simple"/></inline-formula> and is the slope of <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e175" xlink:type="simple"/></inline-formula> versus <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e176" xlink:type="simple"/></inline-formula> at low TIM expression levels (<xref ref-type="fig" rid="pcbi-1003102-g005">Figure 5</xref>). Despite our uncertainty in the relation between relative TIM RNA and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e177" xlink:type="simple"/></inline-formula>, we will show that we can make robust statements regarding the ability of different models to describe the data.</p>
<fig id="pcbi-1003102-g005" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1003102.g005</object-id><label>Figure 5</label><caption>
<title>Relating TIM RNA to peptide abundance.</title>
<p>We use <xref ref-type="disp-formula" rid="pcbi.1003102.e170">equation 6</xref> to connect the TIM peptide abundance <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e178" xlink:type="simple"/></inline-formula> to the expression of TIM RNA relative to controls. Shown are three representative functions using different values of the breadth-parameter <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e179" xlink:type="simple"/></inline-formula>, with location parameter <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e180" xlink:type="simple"/></inline-formula> and saturating TIM abundance <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e181" xlink:type="simple"/></inline-formula>.</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1003102.g005" position="float" xlink:type="simple"/></fig></sec></sec><sec id="s2c">
<title>Parameter estimation</title>
<p>The key parameters of interest were the encounter size <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e182" xlink:type="simple"/></inline-formula> for the <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e183" xlink:type="simple"/></inline-formula> model, and the number of encounters in each phase in the two-phase model. Other parameters were estimated simultaneously, but several quantities were taken as inputs to the models because the data from <xref ref-type="bibr" rid="pcbi.1003102-vanSanten1">[16]</xref> did not allow us to parameterise them directly. These were (i) the parameters specifying the relation between relative RNA expression and absolute peptide abundance; (ii) the distribution of signal strengths obtained by the AND TCR from randomly sampled self pMHC ligands; and (iii) the relation between selection probabilities and absolute cell numbers. First, we explored ranges of parameters defining the mapping function (<xref ref-type="disp-formula" rid="pcbi.1003102.e170">equation 6</xref>); <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e184" xlink:type="simple"/></inline-formula>. We chose to use this generic sigmoid dose-response curve given our ignorance of the mechanistic relation between RNA expression and peptide-MHC abundance on thymic epithelial cells. However, we were able to partially validate this choice of function, and the region of parameter space that we explored, using data from the study by Obst <italic>et al.</italic> <xref ref-type="bibr" rid="pcbi.1003102-Obst1">[58]</xref>. They characterised the relation between the degree of activation of adoptively transferred AND <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e185" xlink:type="simple"/></inline-formula> T cells and the relative TIM RNA expression on MHC class II-expressing cells, using a similar tetracycline-inducible expression system to that used in <xref ref-type="bibr" rid="pcbi.1003102-vanSanten1">[16]</xref>. Their readout of immune activation was the fraction of AND cells that had divided 60 h following induction of TIM expression. Assuming this fraction is linearly related to peptide availability we used the data from Obst <italic>et al.</italic> to estimate the parameters of the mapping function (<xref ref-type="disp-formula" rid="pcbi.1003102.e170">equation 6</xref>). We found that both the recruited fraction and an alternative measure of immune activation, the estimated <italic>per capita</italic> rate of recruitment into division, yielded mappings within the envelope of functions generated with our parameter ranges. These mappings also lay well within the 95% uncertainty envelope generated by the best-fitting parameters from our analysis of the data from <xref ref-type="bibr" rid="pcbi.1003102-vanSanten1">[16]</xref>. For details, see <xref ref-type="supplementary-material" rid="pcbi.1003102.s007">Text S3</xref>, <xref ref-type="supplementary-material" rid="pcbi.1003102.s001">Figure S1</xref> and <xref ref-type="supplementary-material" rid="pcbi.1003102.s004">Table S1</xref>. Second, we assumed the logarithm of the signal strength derived from a single AND-TCR endogenous-pMHC interaction is normally distributed with zero mean and unit variance. The scale of the distribution of signal strengths is arbitrary and its coefficient of variation does not influence our conclusions (see <xref ref-type="sec" rid="s3">Results</xref>). Third, the models provide the probabilities of selection into the T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e186" xlink:type="simple"/></inline-formula> and T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e187" xlink:type="simple"/></inline-formula> lineages and the data are absolute numbers of these populations in the thymus. We relate the numbers to probabilities through a scaling constant derived from the proportion of AND TCR cells that fail negative selection in control mice (<xref ref-type="supplementary-material" rid="pcbi.1003102.s005">Text S1</xref>).</p>
<sec id="s2c1">
<title>Parameter estimation in the <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e188" xlink:type="simple"/></inline-formula>-sum model</title>
<p>The <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e189" xlink:type="simple"/></inline-formula> model is characterised by a further six parameters (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e190" xlink:type="simple"/></inline-formula>) but three could be eliminated or constrained. First, because the AND TCR is strongly selecting we assumed that the probability of any one encounter falling below the positive selection threshold, <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e191" xlink:type="simple"/></inline-formula>, is small. Second, the parameter <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e192" xlink:type="simple"/></inline-formula> is the upper limit on the number of encounters made by a thymocyte during selection, and is expected to be large. Thymocytes move through the medulla and cortex at similar speeds (15 <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e193" xlink:type="simple"/></inline-formula>m/min and 10 <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e194" xlink:type="simple"/></inline-formula>m/min, respectively) <xref ref-type="bibr" rid="pcbi.1003102-LeBorgne1">[59]</xref>. In the medulla, these speeds were shown to be associated with DC contacts at a rate of between 4 and 7 per hour, respectively. If we assume that additional contacts with TECs will contribute up to 50 contacts per hour, and that the time-spent in the thymus is between 5â€“10 days, then 10000 is a plausible upper bound on <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e195" xlink:type="simple"/></inline-formula>. We used a conservative lower bound of <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e196" xlink:type="simple"/></inline-formula>. Thus the probability of all <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e197" xlink:type="simple"/></inline-formula> encounters falling below the positive selection threshold, <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e198" xlink:type="simple"/></inline-formula>, is vanishingly small and we set <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e199" xlink:type="simple"/></inline-formula>. Further, for a given choice of <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e200" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e201" xlink:type="simple"/></inline-formula>, the thresholds for T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e202" xlink:type="simple"/></inline-formula> commitment (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e203" xlink:type="simple"/></inline-formula>) and negative selection (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e204" xlink:type="simple"/></inline-formula>) are determined by the observed probabilities of selection of conventional and regulatory T cells in control mice (<xref ref-type="supplementary-material" rid="pcbi.1003102.s005">Text S1</xref>). Selection in TIM transgenic mice using the <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e205" xlink:type="simple"/></inline-formula> model is then described by three free parameters (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e206" xlink:type="simple"/></inline-formula>, <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e207" xlink:type="simple"/></inline-formula>, <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e208" xlink:type="simple"/></inline-formula>). Only two of these can be identified uniquely, so we explored a discrete set of values of <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e209" xlink:type="simple"/></inline-formula> and for each used a maximum likelihood approach to identify values of <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e210" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e211" xlink:type="simple"/></inline-formula>, the signal strength derived from a single AND TCR contact with TIM agonist. The process was repeated across randomly sampled parameters characterising the mapping function. The residual sum of squares (RSS) and the Akaike information criterion (AIC), where with <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e212" xlink:type="simple"/></inline-formula> observations AICâ€Š=â€Š<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e213" xlink:type="simple"/></inline-formula>(RSS) up to an additive constant, were used to identify the best fitting parameter values. Approximate 95% confidence intervals were generated from the parameter sets that yielded AIC values within 2 units of the lowest value.</p>
</sec><sec id="s2c2">
<title>Parameter estimation in the two-phase model</title>
<p>The predictions of the two-phase model are determined by the TIM mapping function and the three parameters <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e214" xlink:type="simple"/></inline-formula> (<xref ref-type="supplementary-material" rid="pcbi.1003102.s006">Text S2</xref>). We varied <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e215" xlink:type="simple"/></inline-formula>, the probability that a randomly sampled pMHC in phase A will lead to negative selection, between <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e216" xlink:type="simple"/></inline-formula> and 0.1, and used a maximum likelihood approach to identify <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e217" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e218" xlink:type="simple"/></inline-formula>. As above, the process was repeated for a wide range of mapping functions and AIC used to identify best-fitting parameter combinations and approximate 95% confidence intervals.</p>
</sec></sec></sec><sec id="s3">
<title>Results</title>
<sec id="s3a">
<title>Without TCR sensitivity varying during development, a model in which fate decisions derive from single TCR-pMHC contacts is unable to explain the data</title>
<p>The key features of the data are (i) T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e219" xlink:type="simple"/></inline-formula> numbers decline monotonically with agonist expression and (ii) modest increases in agonist expression lead to an increase in the absolute number of AND T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e220" xlink:type="simple"/></inline-formula>, with numbers then decreasing at higher levels of TIM expression (<xref ref-type="fig" rid="pcbi-1003102-g001">Figure 1</xref>). Assuming there is a positive relationship between TIM peptide presentation (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e221" xlink:type="simple"/></inline-formula>) and relative TIM RNA expression, <xref ref-type="disp-formula" rid="pcbi.1003102.e125">equation 4</xref> shows that a model in which fate decisions are re-evaluated after single TCR-pMHC contacts (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e222" xlink:type="simple"/></inline-formula>) can describe the T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e223" xlink:type="simple"/></inline-formula> data, which falls progressively with <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e224" xlink:type="simple"/></inline-formula>.</p>
<p>However, we can see using a graphical argument (<xref ref-type="fig" rid="pcbi-1003102-g006">Figure 6</xref>, upper panel) that the <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e225" xlink:type="simple"/></inline-formula> model with constant TCR sensitivity will only be able to capture the trend in T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e226" xlink:type="simple"/></inline-formula> numbers if encounters comprise TCR signals integrated over multiple pMHC bindings (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e227" xlink:type="simple"/></inline-formula>). If the strength of an interaction between a single AND-TCR and agonist TIM (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e228" xlink:type="simple"/></inline-formula>) lies within the T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e229" xlink:type="simple"/></inline-formula>-selecting range <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e230" xlink:type="simple"/></inline-formula>, we would expect to see a monotonic increase in T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e231" xlink:type="simple"/></inline-formula> numbers with increasing agonist peptide expression; as agonist becomes more abundant, progressively more probability mass is contained within this area, boosting the probability of T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e232" xlink:type="simple"/></inline-formula> selection (<xref ref-type="fig" rid="pcbi-1003102-g005">Figure 5</xref>, upper panel; <xref ref-type="fig" rid="pcbi-1003102-g007">Figure 7A</xref>, dotted-blue curve). Here, the one-hit model predicts that the absolute increase in T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e233" xlink:type="simple"/></inline-formula> numbers is greater than or equal to the absolute decline in T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e234" xlink:type="simple"/></inline-formula> numbers. Conversely, if <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e235" xlink:type="simple"/></inline-formula> is above the threshold for negative selection, <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e236" xlink:type="simple"/></inline-formula>, then we would predict a continuous decrease in T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e237" xlink:type="simple"/></inline-formula> as agonist peptide becomes more abundant and increases the probability of deletion (<xref ref-type="fig" rid="pcbi-1003102-g005">Figure 5</xref>, upper panel; <xref ref-type="fig" rid="pcbi-1003102-g007">Figure 7A</xref>, dashed red curve). Neither of these trends are what is observed and so we rule out these scenarios. Finally, we can exclude the possibility that <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e238" xlink:type="simple"/></inline-formula> lies within the T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e239" xlink:type="simple"/></inline-formula> -selecting range; if <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e240" xlink:type="simple"/></inline-formula>, increasing TIM expression would then increase the probability of selection into T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e241" xlink:type="simple"/></inline-formula>, which we do not observe. Thus we can reject the simple one-hit model for selection of AND thymocytes.</p>
<fig id="pcbi-1003102-g006" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1003102.g006</object-id><label>Figure 6</label><caption>
<title>Modelling T <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e242" xlink:type="simple"/></inline-formula> selection as a function of agonist abundance.</title>
<p><bold>Upper panel</bold> If TCR sensitivity remains static throughout thymic development, the simplest one-hit model fails to explain the rise and fall of T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e243" xlink:type="simple"/></inline-formula> numbers with agonist expression, because the predicted probability of receiving a T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e244" xlink:type="simple"/></inline-formula> selecting signal either increases or decreases monotonically. <bold>Middle panel</bold>. Again with static thresholds, if encounters comprise <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e245" xlink:type="simple"/></inline-formula> contacts with pMHC, and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e246" xlink:type="simple"/></inline-formula>, the distribution of signal strengths from each encounter <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e247" xlink:type="simple"/></inline-formula> is smoother and shifts rightwards with TIM expression, first increasing then decreasing the probability <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e248" xlink:type="simple"/></inline-formula> of triggering T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e249" xlink:type="simple"/></inline-formula> development, as required. <bold>Lower panel</bold>. The two-phase mode also explains the data and allows for encounters comprising single (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e250" xlink:type="simple"/></inline-formula>, illustrated here) or multiple (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e251" xlink:type="simple"/></inline-formula>) TCR-pMHC engagements to dictate fate. The trend in T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e252" xlink:type="simple"/></inline-formula> numbers arises from the balance between an increasing probability of receiving a T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e253" xlink:type="simple"/></inline-formula> -selecting signal with agonist expression in the low-sensitivity phase, and a decreasing probability in the higher-sensitivity phase.</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1003102.g006" position="float" xlink:type="simple"/></fig><fig id="pcbi-1003102-g007" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1003102.g007</object-id><label>Figure 7</label><caption>
<title>Model descriptions of the data.</title>
<p>Representative descriptions of the data by the models. T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e254" xlink:type="simple"/></inline-formula> in blue, T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e255" xlink:type="simple"/></inline-formula> in red. <bold>Panel A</bold>; the one-hit model in which fate decisions are re-evaluated after single TCR-pMHC contacts. The dotted curves, <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e256" xlink:type="simple"/></inline-formula>; dashed curves, <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e257" xlink:type="simple"/></inline-formula>. <bold>Panel B</bold>; the <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e258" xlink:type="simple"/></inline-formula> model; <bold>Panel C</bold>; the two-phase model with <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e259" xlink:type="simple"/></inline-formula>.</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1003102.g007" position="float" xlink:type="simple"/></fig></sec><sec id="s3b">
<title>The data are consistent with a model in which fate decisions derive from integrating multiple TCR-pMHC encounters</title>
<p>Extending the argument above, to explain the rise and fall of T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e260" xlink:type="simple"/></inline-formula> numbers with agonist peptide expression (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e261" xlink:type="simple"/></inline-formula>) requires the probability mass within the T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e262" xlink:type="simple"/></inline-formula>-selecting region to increase then decrease with <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e263" xlink:type="simple"/></inline-formula>. This becomes possible when thymocytes read multiple TCR-pMHC bindings simultaneously (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e264" xlink:type="simple"/></inline-formula>). Qualitatively, this is because when <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e265" xlink:type="simple"/></inline-formula>, replacing an increasing fraction of endogenous peptides with TIM (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e266" xlink:type="simple"/></inline-formula>) right-shifts the distribution of encounter strengths and, in contrast to the <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e267" xlink:type="simple"/></inline-formula> case, increases the probability of an encounter within both the T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e268" xlink:type="simple"/></inline-formula> and negative-selection regions (<xref ref-type="fig" rid="pcbi-1003102-g003">Figure 3B</xref>). The probability contained below the T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e269" xlink:type="simple"/></inline-formula> selection threshold falls with <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e270" xlink:type="simple"/></inline-formula>, consistent with T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e271" xlink:type="simple"/></inline-formula> numbers falling; the probability <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e272" xlink:type="simple"/></inline-formula> of an encounter occurring within the T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e273" xlink:type="simple"/></inline-formula> zone first increases then decreases with <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e274" xlink:type="simple"/></inline-formula>, as required to explain the data; and the probability of negative selection continually increases (<xref ref-type="fig" rid="pcbi-1003102-g006">Figure 6</xref>, middle panel).</p>
<p>We explored this quantitatively and sought to identify the parameters of the <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e275" xlink:type="simple"/></inline-formula> model from the data. They cannot all be identified uniquely. As described in <xref ref-type="sec" rid="s2">Methods</xref> we took the approach of exploring a range of plausible parameters governing the function mapping RNA expression to endogenous peptide replacement by TIM, and a range of values of the maximum number of encounters, <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e276" xlink:type="simple"/></inline-formula>.</p>
<p>Remarkably, all values of <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e277" xlink:type="simple"/></inline-formula> yielded equivalent descriptions of the data, and the encounter size <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e278" xlink:type="simple"/></inline-formula> was highly insensitive to other parameters; it lay between 2 and 5 for all models, with best fitting value <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e279" xlink:type="simple"/></inline-formula>, independent of <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e280" xlink:type="simple"/></inline-formula>. We also found that a range of mapping functions were able to describe the data equally well (<xref ref-type="supplementary-material" rid="pcbi.1003102.s004">Table S1</xref>). In particular, we predict that at maximum RNA expression, TIM replaces beween 0.1% and 12% of endogenous peptides. Representative fits to the data are shown in <xref ref-type="fig" rid="pcbi-1003102-g007">Figure 7</xref>. Panel A illustrates the failure of the one-hit model, with the best fit obtained by forcing <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e281" xlink:type="simple"/></inline-formula>. Panel B shows the fit achieved with the <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e282" xlink:type="simple"/></inline-formula> model with <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e283" xlink:type="simple"/></inline-formula> a free parameter.</p>
<p>The estimate of <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e284" xlink:type="simple"/></inline-formula> is also independent of the variance of the TCR-pMHC signal strength distribution <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e285" xlink:type="simple"/></inline-formula>. This also derives from the fact that the key quantities are just the probabilities <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e286" xlink:type="simple"/></inline-formula> of interactions lying between the different thresholds <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e287" xlink:type="simple"/></inline-formula>. However these thresholds become increasingly spaced with <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e288" xlink:type="simple"/></inline-formula> (that is, as the log-normal distribution becomes increasingly fat-tailed). The less heavy-tailed the distribution of signal strengths, the smaller is the window of affinity/avidity for triggering T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e289" xlink:type="simple"/></inline-formula> development with respect to the mean signal strength. Small increases in affinity can shift TCR signals from positively to negatively selecting <xref ref-type="bibr" rid="pcbi.1003102-Williams1">[2]</xref>, <xref ref-type="bibr" rid="pcbi.1003102-Daniels1">[3]</xref>, and so if signal strength relates linearly to affinity or avidity <xref ref-type="bibr" rid="pcbi.1003102-Lee1">[14]</xref>, our model predicts that the distribution of encounter strengths with self may not be strongly heavy-tailed.</p>
</sec><sec id="s3c">
<title>The estimated encounter size <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e290" xlink:type="simple"/></inline-formula> increases in the presence of null peptides</title>
<p>Anything between ten and a few hundred pMHC have been shown to be required for T cell activation (see for example, <xref ref-type="bibr" rid="pcbi.1003102-Irvine1">[60]</xref>) and as few as 3â€“5 for pMHC recognition by cytotoxic T cell effector function <xref ref-type="bibr" rid="pcbi.1003102-Brower1">[61]</xref>, although with the extent of TCR binding influencing the degree of activation <xref ref-type="bibr" rid="pcbi.1003102-Valitutti1">[42]</xref>. However, data interpreted using the kinetic proofreading model suggest that multiple interactions with very weak ligands may not lead to activation at the whole cell level (see, for example, <xref ref-type="bibr" rid="pcbi.1003102-McKeithan1">[40]</xref>, <xref ref-type="bibr" rid="pcbi.1003102-Germain1">[41]</xref>, <xref ref-type="bibr" rid="pcbi.1003102-Naeher1">[62]</xref>). Therefore we wanted to test whether the low estimates of <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e291" xlink:type="simple"/></inline-formula> are an artefact of the assumption that every TCR-pMHC interaction generates a signal and so an encounter comprising <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e292" xlink:type="simple"/></inline-formula> weak TCR-pMHC bindings might still lead to strong signalling.</p>
<p>To do this, we extended the <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e293" xlink:type="simple"/></inline-formula> model such that only a fraction (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e294" xlink:type="simple"/></inline-formula>) of self-peptides are capable of inducing a signal through the AND TCR, and the remaining fraction <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e295" xlink:type="simple"/></inline-formula> are classifed as null. This introduces a stochastic element to the number of TCR contributing to the signal from each encounter. We found that increasing the abundance of null ligands increases the estimated TCR engagements per encounter (<xref ref-type="supplementary-material" rid="pcbi.1003102.s004">Table S1</xref>). For example, we estimate the number of proximal TCR-pMHC engagements per encounter (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e296" xlink:type="simple"/></inline-formula>) to be between 20â€“190 if 99% of peptides fail to trigger the TCR, and between 350â€“1000 when 99.9% of peptides are null. Intuitively, the increase in <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e297" xlink:type="simple"/></inline-formula> derives from the dilution of the information content of each encounter by the presence of null peptides. For each encounter to be a unit of sufficient information with which fate decisions can be triggered, the sample size <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e298" xlink:type="simple"/></inline-formula> must increase in the presence of null interactions. As for the simpler model (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e299" xlink:type="simple"/></inline-formula>) the estimate of <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e300" xlink:type="simple"/></inline-formula> is also independent of the number of encounters, <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e301" xlink:type="simple"/></inline-formula>.</p>
<p>Therefore, this extended model predicts that in the AND TCR system the expected number of productive TCR-peptide MHC interaction per encounter remains remarkably small (of the order 1). This is perhaps unsurprising, as low values of <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e302" xlink:type="simple"/></inline-formula> will allow thymocytes to discriminate between ligands with small differences in affinity.</p>
</sec><sec id="s3d">
<title>The two-phase model also explains the dependence of T<sub>reg</sub> and T<sub>conv</sub> on agonist expression</title>
<p>Next we explored the implications of a time-varying sensitivity of thymocytes to TCR stimulation during maturation. The two phase model, as described in <xref ref-type="sec" rid="s2">Methods</xref>, extends the one-hit model to include time-varying TCR sensitivity. Its predictions are independent of the direction of variation, but to illustrate we assume an interaction with agonist leads to T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e303" xlink:type="simple"/></inline-formula> commitment during phase A early in development, but causes deletion in phase B when the same peptide is capable of inducing a stronger downstream TCR signal (<xref ref-type="fig" rid="pcbi-1003102-g004">Figure 4</xref>). Selection into the T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e304" xlink:type="simple"/></inline-formula> lineage is still possible in both phases; what changes between phase A and phase B is a right-shift in the distribution of signal strengths with respect to the selection thresholds. This shift in probabilities within the different fate-determining affinity ranges yields the required trends in T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e305" xlink:type="simple"/></inline-formula> and T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e306" xlink:type="simple"/></inline-formula> production with TIM expression (<xref ref-type="fig" rid="pcbi-1003102-g006">Figure 6</xref>, lower panel).</p>
<p>The details of parameter estimation for this model are in <xref ref-type="sec" rid="s2">Methods</xref> and in <xref ref-type="supplementary-material" rid="pcbi.1003102.s006">Text S2</xref>. The unknowns are <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e307" xlink:type="simple"/></inline-formula>, the number of encounters in phase A (Since <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e308" xlink:type="simple"/></inline-formula>, this is the maximum number of pMHC sampled in phase A), <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e309" xlink:type="simple"/></inline-formula>, the number of encounters in phase B, and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e310" xlink:type="simple"/></inline-formula>, the probability that a randomly sampled pMHC in the low-sensitivity phase A will lead to negative selection.</p>
<p>As for the <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e311" xlink:type="simple"/></inline-formula> model, a range mapping functions described the data equally well. A representative fit using the two-phase model is shown in <xref ref-type="fig" rid="pcbi-1003102-g007">Figure 7C</xref>. We found a clear inverse relationship between the value of <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e312" xlink:type="simple"/></inline-formula> and the total number of encounters, <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e313" xlink:type="simple"/></inline-formula>+<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e314" xlink:type="simple"/></inline-formula> (<xref ref-type="fig" rid="pcbi-1003102-g008">Figure 8A</xref>). The model predicts that between 1â€“2% of encounters occur in the lower sensitivity phase (<xref ref-type="fig" rid="pcbi-1003102-g008">Figure 8B</xref>).</p>
<fig id="pcbi-1003102-g008" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1003102.g008</object-id><label>Figure 8</label><caption>
<title>Two phase model.</title>
<p>(A) Total number of encounters (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e315" xlink:type="simple"/></inline-formula>+<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e316" xlink:type="simple"/></inline-formula>) and (B) the proportion of all encounters that take place in phase A, for plausible ranges of <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e317" xlink:type="simple"/></inline-formula>, the proportion of endogenous peptides replaced by TIM at maximum RNA expression.</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1003102.g008" position="float" xlink:type="simple"/></fig></sec><sec id="s3e">
<title>Model discrimination: The two-phase model is required to explain the effect of partial and full agonists on T<sub>reg</sub> selection</title>
<p>We have used data in which there is a profound loss of conventional T cells in the presence of relatively low frequency of agonist peptide, while T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e318" xlink:type="simple"/></inline-formula> numbers are maintained and even initially increase with moderate increases in agonist frequency (<xref ref-type="fig" rid="pcbi-1003102-g001">Figure 1</xref>). These observations suggested the hypothesis that regulatory T cells are intrinsically more resilient to deletion by agonist peptides than conventional T cells <xref ref-type="bibr" rid="pcbi.1003102-vanSanten1">[16]</xref>. Further, the study by Cozzo Picca <italic>et al.</italic> <xref ref-type="bibr" rid="pcbi.1003102-CozzoPicca1">[15]</xref> showed that a partial agonist can induce deletion of conventional T cells but only an agonist could boost regulatory T cell generation. This led to a hypothesis that agonist peptide may deliver a qualitatively different signal that induces regulatory T cells.</p>
<p>We argue that neither of these hypotheses need be invoked. We have shown that both models can explain the first set of observations within a single affinity/avidity framework with different thresholds, without the need to assume differential susceptibilities of T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e319" xlink:type="simple"/></inline-formula> and T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e320" xlink:type="simple"/></inline-formula> to deletion. Further, we can see immediately that the <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e321" xlink:type="simple"/></inline-formula> model will not explain the partial/full agonist observations in ref. <xref ref-type="bibr" rid="pcbi.1003102-CozzoPicca1">[15]</xref>. Their observation that partial agonist increases the probability of deletion with no increase in T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e322" xlink:type="simple"/></inline-formula> suggests that the presence of the partial agonist shifts the distribution of the sum of <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e323" xlink:type="simple"/></inline-formula> interactions far to the right of the wild-type distribution, such that the bulk of the distribution is contained above the negative selection threshold. It follows that strong agonist must push this distribution even further rightwards, and so the probability of signals lying within the T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e324" xlink:type="simple"/></inline-formula>-inducing zone must fall. This is inconsistent with the observed increase in T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e325" xlink:type="simple"/></inline-formula> with agonist strength.</p>
<p>In contrast, the simple two-phase model can explain the effect (<xref ref-type="fig" rid="pcbi-1003102-g009">Figure 9</xref>). Assume that the partial agonist is not strong enough to induce T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e326" xlink:type="simple"/></inline-formula> commitment in phase A when the TCR is relatively insensitive, but in the more sensitive phase B delivers a signal that lies above the negative selection threshold. Then the net effect of introducing a weak agonist is to increase deletion and have little effect on T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e327" xlink:type="simple"/></inline-formula> numbers, as is observed. In contrast, suppose the strong agonist triggers T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e328" xlink:type="simple"/></inline-formula> commitment when the TCR in phase A, but is negatively selecting in phase B (<xref ref-type="fig" rid="pcbi-1003102-g009">Figure 9</xref>, right hand columns). Then (i) expression of the strong agonist will always lead to a fall in conventional T cell numbers, and (ii) moderate levels of strong agonist, while increasing the overall probability of negative selection, can drive a net increase in T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e329" xlink:type="simple"/></inline-formula> production by boosting the probability of receiving a T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e330" xlink:type="simple"/></inline-formula>-inducing signal in phase A.</p>
<fig id="pcbi-1003102-g009" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1003102.g009</object-id><label>Figure 9</label><caption>
<title>Using the two-phase model to explain the dependence of T <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e331" xlink:type="simple"/></inline-formula> development on agonist strength.</title>
<p>Partial agonist (left panels) may drive T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e332" xlink:type="simple"/></inline-formula> commitment in the early phase but induce deletion when TCR sensitivity is increased. In contrast, strong agonist (right panels) may drive T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e333" xlink:type="simple"/></inline-formula> commitment early, and despite triggering deletion later, the net effect is still a net increase in T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e334" xlink:type="simple"/></inline-formula> numbers. For clarity we illustrate here with the signal-strength distribution derived from <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e335" xlink:type="simple"/></inline-formula>, as in the basic two-phase model, but the argument holds also for a generalised two-phase model with encounters of size <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e336" xlink:type="simple"/></inline-formula> (<xref ref-type="supplementary-material" rid="pcbi.1003102.s002">Figure S2</xref>).</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1003102.g009" position="float" xlink:type="simple"/></fig>
<p><xref ref-type="fig" rid="pcbi-1003102-g009">Figure 9</xref> illustrates this effect for the case <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e337" xlink:type="simple"/></inline-formula>, but the same argument holds for a generalisation of the two-phase model with <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e338" xlink:type="simple"/></inline-formula> (<xref ref-type="supplementary-material" rid="pcbi.1003102.s002">Figure S2</xref>).</p>
</sec></sec><sec id="s4">
<title>Discussion</title>
<p>How does a thymocyte decide to become a conventional or regulatory T cell, or die, and when are these decisions most likely to take place? To address these questions, we have used experimental data to test models of how thymocytes interpret TCR interactions with self-peptide MHC to make fate decisions. We showed that the data cannot be explained with a model in which (from a given TCR's perspective) individual self-peptide MHC ligands are classed as positively selecting, negatively selecting or promoting T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e339" xlink:type="simple"/></inline-formula> development, and in which a single engagement with a strong agonist pMHC is sufficient to influence cell fate. Instead we found stronger and roughly equivalent support for two alternative models, in which (i) a thymocyte bases decisions on TCR signals summed from multiple engagements with pMHC ligands, and/or (ii) a two-phase model in which TCR sensitivity alters during development, and so an engagement with the same pMHC ligand may lead to divergent outcomes at different stages of development. A robust prediction of the <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e340" xlink:type="simple"/></inline-formula> model is that the number of non-null TCR-self-peptide interactions per encounter that contribute to fate decisions is remarkably small. The two-phase model predicts that the initiation of differentiation into the T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e341" xlink:type="simple"/></inline-formula> lineage is most efficient during a relatively short temporal window during which the TCR is less sensitive to stimulation. Importantly, the models express the probabilistic aspect of thymic selection that likely underlies the heterogeneity in lineage decisions within a clonotypic population.</p>
<sec id="s4a">
<title>Explaining selection efficiency as a function of TCR affinity</title>
<p>We focused here on a system in which agonist availability could be manipulated. We can also use the models to make predictions regarding selection efficiency as a function of TCR affinity. Lee et al. <xref ref-type="bibr" rid="pcbi.1003102-Lee1">[14]</xref> quantified the efficiency of T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e342" xlink:type="simple"/></inline-formula> selection in the rat insulin promoter (RIP)-mOVA system for a range of <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e343" xlink:type="simple"/></inline-formula> TCR clones with varying affinity for OVA. They found T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e344" xlink:type="simple"/></inline-formula> were generated across a broad range of reactivities and found an increase in T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e345" xlink:type="simple"/></inline-formula> selection efficiency with increasing affinity for a self peptide. Both the <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e346" xlink:type="simple"/></inline-formula> and variable-sensitivity models are able to explain these observations (<xref ref-type="supplementary-material" rid="pcbi.1003102.s008">Text S4</xref> and <xref ref-type="supplementary-material" rid="pcbi.1003102.s003">Figure S3</xref>), but they make distinct predictions. The <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e347" xlink:type="simple"/></inline-formula> model predicts that the probability of the summed-proximal signals at each encounter exceeding the T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e348" xlink:type="simple"/></inline-formula> threshold is lower for weaker clones; but this probability remains constant throughout development. A variable-sensitivity model predicts that T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e349" xlink:type="simple"/></inline-formula> selection efficiency is determined by the duration of the window in which agonist contact triggers T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e350" xlink:type="simple"/></inline-formula> commitment. In an increasing-sensitivity scenario, clones that recognise OVA more weakly will take longer to reach a level of TCR sensitivity that can induce T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e351" xlink:type="simple"/></inline-formula>, and so a prediction of the model is that lower-affinity TCR clones will commit to the T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e352" xlink:type="simple"/></inline-formula> lineage later in development.</p>
<p>These models might be distinguished by manipulating thymocytes' TCR sensitivity, for example through altered expression of signalling proteins, at different stages of thymocyte development. The <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e353" xlink:type="simple"/></inline-formula> model predicts that the efficiency of T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e354" xlink:type="simple"/></inline-formula> selection would be altered equally for all clones, whereas a model of increasing TCR sensitivity predicts that damping of TCR signalling later in development would most strongly reduce T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e355" xlink:type="simple"/></inline-formula> selection efficiency for clones with low affinity for self peptide.</p>
</sec><sec id="s4b">
<title>Robustness of results despite parameter uncertainties</title>
<p>We deliberately did not use model selection criteria to discriminate between models, in part because it is not possible to identify all parameters uniquely. Instead we identified regions of parameter space for each model that provided reasonable descriptions of the data. Importantly, the predicted values of the encounter size <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e356" xlink:type="simple"/></inline-formula> for different abundances of null peptides (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e357" xlink:type="simple"/></inline-formula>) are insensitive to the remaining parameters (<xref ref-type="supplementary-material" rid="pcbi.1003102.s004">Table S1</xref>). We consider the <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e358" xlink:type="simple"/></inline-formula> and two-phase models capable of describing the data equally well because they are able to capture the decline in T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e359" xlink:type="simple"/></inline-formula> and increase then decrease in T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e360" xlink:type="simple"/></inline-formula> with TIM abundance. Both models capture this behaviour provided TIM abundance increases monotonically with RNA expression, which we expect to be the case. Further, model selection criteria are not required to reject the simplest one-hit model, nor to compare the abilities of the <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e361" xlink:type="simple"/></inline-formula> and two-phase models to describe the partial agonist observations.</p>
</sec><sec id="s4c">
<title>The effect of integrating many intermediate affinity binding events</title>
<p>One prediction of an avidity-based model is that thymocytes may be deleted if they interact simultaneously with several pMHC at moderate affinities. We believe this prediction is not necessarily unreasonable; such events may be an inevitable byproduct of a selection process that is inherently probabilistic and which can result in cells with identical TCR experiencing divergent fates.</p>
</sec><sec id="s4d">
<title>Generalisations of the two models</title>
<p>The two mechanisms we explore here are not mutually exclusive. We illustrated the two-phase model assuming that decisions are made based on single, rather than summed interactions with pMHC. However it can be generalised to an extended version of the <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e362" xlink:type="simple"/></inline-formula> model in which encounters are interpreted differently as TCR sensitivity increases. This model will be able to explain the observations a least as well as the <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e363" xlink:type="simple"/></inline-formula> or two phase models, at the cost of extra parameters. Also, we illustrated the impact of increasing TCR sensitivity with a simple model that divided development into two discrete phases, while increases in TCR sensitivity are likely to be continuous. Modelling smooth changes in TCR sensitivity will introduce additional parameters but we expect such a model to yield qualitatively similar results. Importantly, our analysis does not exclude the possibility that T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e364" xlink:type="simple"/></inline-formula> are more resistant to deletion and/or that qualitatively different signals are involved in T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e365" xlink:type="simple"/></inline-formula> and T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e366" xlink:type="simple"/></inline-formula> commitment; we simply show that these mechanisms need not be invoked to explain the observations.</p>
</sec><sec id="s4e">
<title>The nature of positively selecting signals</title>
<p>There is evidence that positive selection requires multiple low-affinity contacts with self-peptides in the thymus <xref ref-type="bibr" rid="pcbi.1003102-Hogquist1">[63]</xref>â€“<xref ref-type="bibr" rid="pcbi.1003102-NikoliZugi1">[65]</xref>. In contrast, in our model, a single encounter above the threshold <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e367" xlink:type="simple"/></inline-formula> is sufficient for positive selection. We assumed this threshold is very low for the AND thymocytes, which are strongly selecting under normal conditions. These cells will presumably receive essentially continuous positively selecting signals. In the general case, and particularly for weakly signalling TCRs that are near the threshold for death by neglect, the threshold <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e368" xlink:type="simple"/></inline-formula> would need to be included in the parameter search and the model would be extended to include a memory of recent interactions; one possibility is a model in which levels of survival or fate-determining proteins are increased by TCR signalling but decay in its absence.</p>
</sec><sec id="s4f">
<title>The role of precursor frequency in limiting T<sub>reg</sub> development</title>
<p>There is substantial evidence that increasing the frequency of a given clonal (single TCR specificity) population reduces its efficiency of selection and in particular the probability of being directed into the T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e369" xlink:type="simple"/></inline-formula> lineage <xref ref-type="bibr" rid="pcbi.1003102-Lee1">[14]</xref>, <xref ref-type="bibr" rid="pcbi.1003102-Bautista1">[22]</xref>, <xref ref-type="bibr" rid="pcbi.1003102-Moran1">[24]</xref>. Our models treat cells as independent entities and do not explicitly incorporate the possibility that competition between thymocytes of similar TCR specificities might influence the availability of selecting ligands. However one mechanism of competition can be represented quite straightforwardly in the models. If the strength of an encounter correlates with its duration, or perhaps increases the probability of internalisation of the pMHC ligand by the thymocyte, the TCR-specific cells will compete for and possibly sequester agonist and other high-avidity pMHC ligands. This will shift the apparent distribution of signal strengths leftwards towards lower avidity (and more available) interactions, reducing the probability of acquiring T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e370" xlink:type="simple"/></inline-formula>-selecting signals. This model of competition for higher-avidity pMHC ligands may also explain the observation that the efficiency of T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e371" xlink:type="simple"/></inline-formula> selection can increase with precursor frequency <xref ref-type="bibr" rid="pcbi.1003102-Bautista1">[22]</xref>. However it remains an open question whether competition for pMHC plays an important role in selection at physiological precursor frequencies.</p>
</sec><sec id="s4g">
<title>Cytokine requirements for T<sub>reg</sub> development</title>
<p>Signalling through the IL-2 receptor is a requirement for T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e372" xlink:type="simple"/></inline-formula> development <xref ref-type="bibr" rid="pcbi.1003102-Lio1">[66]</xref>â€“<xref ref-type="bibr" rid="pcbi.1003102-Cheng1">[68]</xref>. It is thought that strong TCR signalling below the negative selection threshold may sensitise cells to IL-2, licensing progression towards the T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e373" xlink:type="simple"/></inline-formula> lineage. Whatever the precise role for IL-2, it must operate downstream of fate-determining signals if selection is governed by a hierarchy of TCR avidity thresholds. Nevertheless, if IL-2 is limiting it may provide an upper bound on the total rate of production of T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e374" xlink:type="simple"/></inline-formula>, either by redirection of cells to the T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e375" xlink:type="simple"/></inline-formula> lineage or through loss. We argue however that competition for non-specific factors is unlikely to play a significant role in the system we are working with. First, the source of the IL-2 is unclear but we can reasonably suppose that IL-2 production in this system is independent of TIM expression. T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e376" xlink:type="simple"/></inline-formula> numbers increase with TIM at low expression levels, indicating that IL-2 cannot be limiting in this region (<xref ref-type="fig" rid="pcbi-1003102-g001">Figure 1</xref>). Similarly it cannot be limiting at higher TIM levels as T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e377" xlink:type="simple"/></inline-formula> decrease. It remains possible that a capping of T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e378" xlink:type="simple"/></inline-formula> production through competition for IL-2 may be occuring in a small flat region near the peak in T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e379" xlink:type="simple"/></inline-formula> numbers, but competition for non-specific factors alone cannot explain the key aspects of T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e380" xlink:type="simple"/></inline-formula> development we are attempting to describe.</p>
</sec><sec id="s4h">
<title>Predictions of the models regarding the timing of regulatory T cell commitment</title>
<p>Early neonatal thymectomy experiments suggested that the development of T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e381" xlink:type="simple"/></inline-formula> is delayed compared to conventional T cells <xref ref-type="bibr" rid="pcbi.1003102-Nishizuka1">[69]</xref>â€“<xref ref-type="bibr" rid="pcbi.1003102-Fontenot1">[71]</xref>. A key T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e382" xlink:type="simple"/></inline-formula> marker, the transcription factor Foxp3, is predominantly observed in the mature CD4 single positive stage of thymocyte development <xref ref-type="bibr" rid="pcbi.1003102-Lee2">[72]</xref>. However, there may be a lag between initiation of T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e383" xlink:type="simple"/></inline-formula> development and the stable expression of Foxp3; and it is possible that factors required for T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e384" xlink:type="simple"/></inline-formula> development such as IL-2 <xref ref-type="bibr" rid="pcbi.1003102-Lio1">[66]</xref>â€“<xref ref-type="bibr" rid="pcbi.1003102-Cheng1">[68]</xref> or medullary thymic epithelial cells <xref ref-type="bibr" rid="pcbi.1003102-Cowan1">[73]</xref> may only be required later in the maturation process. Thus the timing of T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e385" xlink:type="simple"/></inline-formula> commitment remains unclear. The two models explored here make different predictions regarding this timing. The <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e386" xlink:type="simple"/></inline-formula> model suggests that diversion into the regulatory T cell lineage occurs with constant probability per encounter throughout selection. In contrast, the key prediction of the two-phase model is that the development of AND TCR T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e387" xlink:type="simple"/></inline-formula> is triggered most efficiently within a relative short window during which thymocytes are relatively insensitive to TCR signalling. This window is estimated to span roughly 2% of the total pMHC ligands sampled, with the caveat that the two-phase model is an abstraction of what is more likely to be a temporally graded shift in sensitivity.</p>
<p>The two-phase model's predictions are identical whether the shorter, less sensitive phase occurs early or late in development. However, expression of the downstream TCR-signalling protein Zap70 increases progressively between the double positive (DP) and single positive stages of thymocyte development, and is associated with increasing sensitivity to TCR stimulation <xref ref-type="bibr" rid="pcbi.1003102-Saini1">[28]</xref>; immature DP thymocytes display lower surface expression of TCRs, as compared to mature single positive (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e388" xlink:type="simple"/></inline-formula> or <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e389" xlink:type="simple"/></inline-formula>) thymocytes, and TCR signalling may be actively inhibited in immature DPs <xref ref-type="bibr" rid="pcbi.1003102-Nakayama1">[74]</xref>. Thymocytes' signalling environment may also change as they develop. Selection begins in the thymic cortex, where pMHC are encountered on cortical thymic epithelial cells, before cells migrate to the medulla where they encounter pMHC on medullary thymic epithelial cells and dendritic cells. It is thought that levels of co-stimulation and antigen presentation are generally lower in the cortex than in the medulla <xref ref-type="bibr" rid="pcbi.1003102-Lorenz1">[75]</xref>â€“<xref ref-type="bibr" rid="pcbi.1003102-Gray1">[77]</xref>, suggesting that there may be an effective increase in TCR signalling during development. Using these observations, the two-phase model predicts that T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e390" xlink:type="simple"/></inline-formula> development begins predominantly, but not exclusively, during a short window at the earliest double positive stage of selection. Clearly, definitive experimental identification of when T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e391" xlink:type="simple"/></inline-formula> development is initiated will substantially increase our understanding of how thymocytes process information.</p>
</sec><sec id="s4i">
<title>Ligand discrimination â€” a role for time-varying TCR sensitivity in the thymus?</title>
<p>Reliable recognition and discrimination of self and nonself ligands requires both TCR sensitivity and specificity. Specificity will decrease as the number of pMHC integrated per encounter (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e392" xlink:type="simple"/></inline-formula>) increases â€” when <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e393" xlink:type="simple"/></inline-formula> is large, many pMHC engagements are integrated at each encounter, and so the thymocyte is then just sampling the mean of the distribution of pMHC affinities, and information is lost. This may explain why the optimum values of <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e394" xlink:type="simple"/></inline-formula> in the <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e395" xlink:type="simple"/></inline-formula> model are at the lower end of the reported numbers of pMHC engagements required for T cell activation; T cell activation may invole a relatively small number of informative TCR recognition events, together with many brief engagements with null or very low affinity peptide ligands. Our analysis of the <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e396" xlink:type="simple"/></inline-formula> model places small lower bounds on the number of non-null TCR engagements per encounter; but the two-phase model explains the data by allowing even a single non-null pMHC recognition event to influence fate. We speculate that varying TCR sensitivity with time in the thymus may allow for increased specificity in self-nonself discrimination.</p>
</sec></sec><sec id="s5">
<title>Supporting Information</title>
<supplementary-material id="pcbi.1003102.s001" mimetype="application/postscript" xlink:href="info:doi/10.1371/journal.pcbi.1003102.s001" position="float" xlink:type="simple"><label>Figure S1</label><caption>
<p><bold>Fitting the TIM mapping function to various readouts of immune activation derived from the data in Obst </bold><bold><italic>et al.</italic></bold> <xref ref-type="bibr" rid="pcbi.1003102-Obst1">[<bold>58</bold>]</xref><bold>.</bold> <bold>Upper row</bold>: Our proposed sigmoid mapping function yielded reasonable descriptions of three readouts of immune activation, all assumed to be proportional to peptide abundance on APC. <bold>Lower panel</bold>: we show the best fitting functions derived from the three measures superimposed on the 95% uncertainty envelope in mapping functions derived from the best-fitting parameters of the <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e397" xlink:type="simple"/></inline-formula> model. Assuming TIM abundance was proportional to the recruited fraction at 60 h (red curve) or to the per capita rate of recruitment (orange curve) yielded functions that lay well within this region.</p>
<p>(EPS)</p>
</caption></supplementary-material><supplementary-material id="pcbi.1003102.s002" mimetype="application/postscript" xlink:href="info:doi/10.1371/journal.pcbi.1003102.s002" position="float" xlink:type="simple"><label>Figure S2</label><caption>
<p><bold>Explaining the effect of partial and strong agonists on T</bold><inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e398" xlink:type="simple"/></inline-formula><bold> selection efficiency.</bold> <xref ref-type="fig" rid="pcbi-1003102-g009">Figure 9</xref> in the main text illustrates how the observations of Cozzo Picca <italic>et al.</italic> <xref ref-type="bibr" rid="pcbi.1003102-CozzoPicca1">[15]</xref> regarding the effect of partial and strong agonists on T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e399" xlink:type="simple"/></inline-formula> selection efficiency can be explained with the two phase model. This model can be extended to include multiple pMHC per encounter and with it a similar schematic can be used to explain the observations. As before, the temporal order of the low and high TCR sensitivity phases has no effect on our results; here we illustrate the argument for an increasing-sensitivity model. The presence of partial agonist may make T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e400" xlink:type="simple"/></inline-formula> commitment far more likely than T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e401" xlink:type="simple"/></inline-formula> commitment in phase of lower TCR sensitivity (upper left panel). Increasing TCR sensitivity then may predominantly induce deletion (lower left panel). In contrast, strong agonist (right panels) may yield a higher probability of T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e402" xlink:type="simple"/></inline-formula> commitment when TCR sensitivity is lower but, as with a partial agonist, predominantly trigger deletion when TCR sensitivity increases. The net effect is an increase in T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e403" xlink:type="simple"/></inline-formula> numbers as we shift from partial to strong agonist.</p>
<p>(EPS)</p>
</caption></supplementary-material><supplementary-material id="pcbi.1003102.s003" mimetype="application/postscript" xlink:href="info:doi/10.1371/journal.pcbi.1003102.s003" position="float" xlink:type="simple"><label>Figure S3</label><caption>
<p><bold>Alternative models of T</bold><inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e404" xlink:type="simple"/></inline-formula><bold> selection for TCR clonotypes with varying sensitivity to endogenously expressed ovalbumin (OVA) peptide, as used in Lee </bold><bold><italic>et al.</italic></bold><bold> </bold><xref ref-type="bibr" rid="pcbi.1003102-Lee1">[<bold>14</bold>]</xref><bold>.</bold> In the <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e405" xlink:type="simple"/></inline-formula> model (<bold>upper panel</bold>), each curve represents the distribution of summed signal strengths (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e406" xlink:type="simple"/></inline-formula>) for TCRs with varying affinity for endogenously expressed OVA peptide. The probability that the summed signal from multiple pMHC contacts leads to T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e407" xlink:type="simple"/></inline-formula> commitment is higher for TCR with higher affinity for OVA, and this probability remains constant for each encounter throughout development. In the varying-TCR sensitivity model (<bold>lower panel</bold>), each curve represents the strength of signal derived from a single contact with OVA for each TCR as a function of time. There is a window of susceptibility in which contact with an OVA pMHC will lead to T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e408" xlink:type="simple"/></inline-formula> commitment; the probability of a contact with OVA is equal for all TCR, but the duration and timing of this window will vary for each TCR as a function of its initial ability to respond to OVA. (The blue line represents TCR with highest affinity for OVA; and orange represents TCR with the weakest affinity for OVA).</p>
<p>(EPS)</p>
</caption></supplementary-material><supplementary-material id="pcbi.1003102.s004" mimetype="application/pdf" xlink:href="info:doi/10.1371/journal.pcbi.1003102.s004" position="float" xlink:type="simple"><label>Table S1</label><caption>
<p><bold>Plausible combinations of parameters of the </bold><inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e409" xlink:type="simple"/></inline-formula><bold> model.</bold> We used discrete combinations of <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e410" xlink:type="simple"/></inline-formula>, the maximum number of APC encounters made by a thymocyte, and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e411" xlink:type="simple"/></inline-formula>, the fraction of endogenous peptides that are capable of inducing a TCR signal. Mean (minimum, maximum) values correspond to parameter combinations that described the data within <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e412" xlink:type="simple"/></inline-formula>AIC<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e413" xlink:type="simple"/></inline-formula>2 of the lowest AIC achieved for each (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e414" xlink:type="simple"/></inline-formula>,<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e415" xlink:type="simple"/></inline-formula>) combination. <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e416" xlink:type="simple"/></inline-formula> is the number of peptides contacted per APC encounter; <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e417" xlink:type="simple"/></inline-formula> reflects the signal derived from a single TCR contact with agonist TIM (as a percentile of signal strengths derived from contacts with non-null endogenous peptides); <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e418" xlink:type="simple"/></inline-formula> represents the minimal signal required for T<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e419" xlink:type="simple"/></inline-formula> selection; <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e420" xlink:type="simple"/></inline-formula> represents the minimal signal required for negative selection (percentile of signal strengths received per encounter (with functional and null endogenous peptides)); and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e421" xlink:type="simple"/></inline-formula>, <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e422" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e423" xlink:type="simple"/></inline-formula> parameterise the mapping function from relative TIM RNA to peptide abundance.</p>
<p>(PDF)</p>
</caption></supplementary-material><supplementary-material id="pcbi.1003102.s005" mimetype="application/pdf" xlink:href="info:doi/10.1371/journal.pcbi.1003102.s005" position="float" xlink:type="simple"><label>Text S1</label><caption>
<p><bold>The calculation of the selection probabilities in the </bold><inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e424" xlink:type="simple"/></inline-formula><bold> model.</bold></p>
<p>(PDF)</p>
</caption></supplementary-material><supplementary-material id="pcbi.1003102.s006" mimetype="application/pdf" xlink:href="info:doi/10.1371/journal.pcbi.1003102.s006" position="float" xlink:type="simple"><label>Text S2</label><caption>
<p><bold>The calculation of the selection probabilities in the two-phase model.</bold></p>
<p>(PDF)</p>
</caption></supplementary-material><supplementary-material id="pcbi.1003102.s007" mimetype="application/pdf" xlink:href="info:doi/10.1371/journal.pcbi.1003102.s007" position="float" xlink:type="simple"><label>Text S3</label><caption>
<p><bold>Exploring the relation between relative TIM RNA expression and immune activation.</bold></p>
<p>(PDF)</p>
</caption></supplementary-material><supplementary-material id="pcbi.1003102.s008" mimetype="application/pdf" xlink:href="info:doi/10.1371/journal.pcbi.1003102.s008" position="float" xlink:type="simple"><label>Text S4</label><caption>
<p><bold>Explaining variation in T</bold><inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003102.e425" xlink:type="simple"/></inline-formula><bold> selection efficiency with TCR affinity.</bold></p>
<p>(PDF)</p>
</caption></supplementary-material></sec></body>
<back>
<ack>
<p>We thank Christophe Benoist for discussion and comments and Reinhard Obst for providing the raw data for the test of the RNA vs peptide occupancy model.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="pcbi.1003102-Wing1"><label>1</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wing</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Sakaguchi</surname><given-names>S</given-names></name> (<year>2010</year>) <article-title>Regulatory T cells exert checks and balances on self tolerance and autoimmunity</article-title>. <source>Nat Immunol</source> <volume>11</volume>: <fpage>7</fpage>â€“<lpage>13</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003102-Williams1"><label>2</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Williams</surname><given-names>CB</given-names></name>, <name name-style="western"><surname>Engle</surname><given-names>DL</given-names></name>, <name name-style="western"><surname>Kersh</surname><given-names>GJ</given-names></name>, <name name-style="western"><surname>Michael White</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Allen</surname><given-names>PM</given-names></name> (<year>1999</year>) <article-title>A kinetic threshold between negative and positive selection based on the longevity of the T cell receptor-ligand complex</article-title>. <source>J Exp Med</source> <volume>189</volume>: <fpage>1531</fpage>â€“<lpage>44</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003102-Daniels1"><label>3</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Daniels</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Teixeiro</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Gill</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Hausmann</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Roubaty</surname><given-names>D</given-names></name>, <etal>et al</etal>. (<year>2006</year>) <article-title>Thymic selection threshold defined by compartmentalization of Ras/MAPK signalling</article-title>. <source>Nature</source> <volume>444</volume>: <fpage>724</fpage>â€“<lpage>9</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003102-Maloy1"><label>4</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Maloy</surname><given-names>KJ</given-names></name>, <name name-style="western"><surname>Powrie</surname><given-names>F</given-names></name> (<year>2001</year>) <article-title>Regulatory T cells in the control of immune pathology</article-title>. <source>Nat Immunol</source> <volume>2</volume>: <fpage>816</fpage>â€“<lpage>22</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003102-Hsieh1"><label>5</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hsieh</surname><given-names>CS</given-names></name>, <name name-style="western"><surname>Liang</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Tyznik</surname><given-names>AJ</given-names></name>, <name name-style="western"><surname>Self</surname><given-names>SG</given-names></name>, <name name-style="western"><surname>Liggitt</surname><given-names>D</given-names></name>, <etal>et al</etal>. (<year>2004</year>) <article-title>Recognition of the peripheral self by naturally arising CD25+ CD4+ T cell receptors</article-title>. <source>Immunity</source> <volume>21</volume>: <fpage>267</fpage>â€“<lpage>77</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003102-Bettini1"><label>6</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bettini</surname><given-names>ML</given-names></name>, <name name-style="western"><surname>Vignali</surname><given-names>DAA</given-names></name> (<year>2010</year>) <article-title>Development of thymically derived natural regulatory T cells</article-title>. <source>Ann N Y Acad Sci</source> <volume>1183</volume>: <fpage>1</fpage>â€“<lpage>12</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003102-Romagnoli1"><label>7</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Romagnoli</surname><given-names>P</given-names></name>, <name name-style="western"><surname>van Meerwijk</surname><given-names>JPM</given-names></name> (<year>2010</year>) <article-title>Thymic selection and lineage commitment of CD4(+)Foxp3(+) regulatory T lymphocytes</article-title>. <source>Prog Mol Biol Transl Sci</source> <volume>92</volume>: <fpage>251</fpage>â€“<lpage>77</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003102-Wong1"><label>8</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wong</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Obst</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Correia-Neves</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Losyev</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Mathis</surname><given-names>D</given-names></name>, <etal>et al</etal>. (<year>2007</year>) <article-title>Adaptation of TCR repertoires to self-peptides in regulatory and nonregulatory CD4+ T cells</article-title>. <source>J Immunol</source> <volume>178</volume>: <fpage>7032</fpage>â€“<lpage>41</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003102-Jordan1"><label>9</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jordan</surname><given-names>MS</given-names></name>, <name name-style="western"><surname>Boesteanu</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Reed</surname><given-names>AJ</given-names></name>, <name name-style="western"><surname>Petrone</surname><given-names>AL</given-names></name>, <name name-style="western"><surname>Holenbeck</surname><given-names>AE</given-names></name>, <etal>et al</etal>. (<year>2001</year>) <article-title>Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide</article-title>. <source>Nat Immunol</source> <volume>2</volume>: <fpage>301</fpage>â€“<lpage>6</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003102-Apostolou1"><label>10</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Apostolou</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Sarukhan</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Klein</surname><given-names>L</given-names></name>, <name name-style="western"><surname>von Boehmer</surname><given-names>H</given-names></name> (<year>2002</year>) <article-title>Origin of regulatory T cells with known specificity for antigen</article-title>. <source>Nat Immunol</source> <volume>3</volume>: <fpage>756</fpage>â€“<lpage>63</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003102-Kawahata1"><label>11</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kawahata</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Misaki</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Yamauchi</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Tsunekawa</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Setoguchi</surname><given-names>K</given-names></name>, <etal>et al</etal>. (<year>2002</year>) <article-title>Generation of CD4(+)CD25(+) regulatory T cells from autoreactive T cells simultaneously with their negative selection in the thymus and from nonautoreactive T cells by endogenous TCR expression</article-title>. <source>J Immunol</source> <volume>168</volume>: <fpage>4399</fpage>â€“<lpage>405</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003102-Aschenbrenner1"><label>12</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Aschenbrenner</surname><given-names>K</given-names></name>, <name name-style="western"><surname>D'Cruz</surname><given-names>LM</given-names></name>, <name name-style="western"><surname>Vollmann</surname><given-names>EH</given-names></name>, <name name-style="western"><surname>Hinterberger</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Emmerich</surname><given-names>J</given-names></name>, <etal>et al</etal>. (<year>2007</year>) <article-title>Selection of Foxp3+ regulatory T cells specific for self antigen expressed and presented by Aire+ medullary thymic epithelial cells</article-title>. <source>Nat Immunol</source> <volume>8</volume>: <fpage>351</fpage>â€“<lpage>8</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003102-Larkin1"><label>13</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Larkin</surname><given-names>J</given-names><suffix>3rd</suffix></name>, <name name-style="western"><surname>Rankin</surname><given-names>AL</given-names></name>, <name name-style="western"><surname>Picca</surname><given-names>CC</given-names></name>, <name name-style="western"><surname>Riley</surname><given-names>MP</given-names></name>, <name name-style="western"><surname>Jenks</surname><given-names>SA</given-names></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>CD4+CD25+ regulatory T cell repertoire formation shaped by differential presentation of peptides from a self-antigen</article-title>. <source>J Immunol</source> <volume>180</volume>: <fpage>2149</fpage>â€“<lpage>57</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003102-Lee1"><label>14</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lee</surname><given-names>HM</given-names></name>, <name name-style="western"><surname>Bautista</surname><given-names>JL</given-names></name>, <name name-style="western"><surname>Scott-Browne</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Mohan</surname><given-names>JF</given-names></name>, <name name-style="western"><surname>Hsieh</surname><given-names>CS</given-names></name> (<year>2012</year>) <article-title>A broad range of self-reactivity drives thymic regulatory T cell selection to limit responses to self</article-title>. <source>Immunity</source> <volume>37</volume>: <fpage>475</fpage>â€“<lpage>86</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003102-CozzoPicca1"><label>15</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cozzo Picca</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Simons</surname><given-names>DM</given-names></name>, <name name-style="western"><surname>Oh</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Aitken</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Perng</surname><given-names>OA</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>CD4+CD25+Foxp3+ regulatory T cell formation requires more specific recognition of a self-peptide than thymocyte deletion</article-title>. <source>Proc Natl Acad Sci U S A</source> <volume>108</volume>: <fpage>14890</fpage>â€“<lpage>5</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003102-vanSanten1"><label>16</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>van Santen</surname><given-names>HM</given-names></name>, <name name-style="western"><surname>Benoist</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Mathis</surname><given-names>D</given-names></name> (<year>2004</year>) <article-title>Number of T reg cells that differentiate does not increase upon encounter of agonist ligand on thymic epithelial cells</article-title>. <source>J Exp Med</source> <volume>200</volume>: <fpage>1221</fpage>â€“<lpage>30</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003102-CozzoPicca2"><label>17</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cozzo Picca</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Oh</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Panarey</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Aitken</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Basehoar</surname><given-names>A</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>Thymocyte deletion can bias Treg formation toward low-abundance self-peptide</article-title>. <source>Eur J Immunol</source> <volume>39</volume>: <fpage>3301</fpage>â€“<lpage>6</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003102-Atibalentja1"><label>18</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Atibalentja</surname><given-names>DF</given-names></name>, <name name-style="western"><surname>Byersdorfer</surname><given-names>CA</given-names></name>, <name name-style="western"><surname>Unanue</surname><given-names>ER</given-names></name> (<year>2009</year>) <article-title>Thymus-blood protein interactions are highly effective in negative selection and regulatory T cell induction</article-title>. <source>J Immunol</source> <volume>183</volume>: <fpage>7909</fpage>â€“<lpage>18</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003102-Sebzda1"><label>19</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sebzda</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Wallace</surname><given-names>VA</given-names></name>, <name name-style="western"><surname>Mayer</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Yeung</surname><given-names>RS</given-names></name>, <name name-style="western"><surname>Mak</surname><given-names>TW</given-names></name>, <etal>et al</etal>. (<year>1994</year>) <article-title>Positive and negative thymocyte selection induced by different concentrations of a single peptide</article-title>. <source>Science</source> <volume>263</volume>: <fpage>1615</fpage>â€“<lpage>8</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003102-Lerman1"><label>20</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lerman</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Larkin</surname><given-names>J</given-names><suffix>3rd</suffix></name>, <name name-style="western"><surname>Cozzo</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Jordan</surname><given-names>MS</given-names></name>, <name name-style="western"><surname>Caton</surname><given-names>AJ</given-names></name> (<year>2004</year>) <article-title>CD4+ CD25+ regulatory T cell repertoire formation in response to varying expression of a neo-self-antigen</article-title>. <source>J Immunol</source> <volume>173</volume>: <fpage>236</fpage>â€“<lpage>44</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003102-Feuerer1"><label>21</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Feuerer</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Jiang</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Holler</surname><given-names>PD</given-names></name>, <name name-style="western"><surname>Satpathy</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Campbell</surname><given-names>C</given-names></name>, <etal>et al</etal>. (<year>2007</year>) <article-title>Enhanced thymic selection of FoxP3+ regulatory T cells in the NOD mouse model of autoimmune diabetes</article-title>. <source>Proc Natl Acad Sci U S A</source> <volume>104</volume>: <fpage>18181</fpage>â€“<lpage>6</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003102-Bautista1"><label>22</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bautista</surname><given-names>JL</given-names></name>, <name name-style="western"><surname>Lio</surname><given-names>CWJ</given-names></name>, <name name-style="western"><surname>Lathrop</surname><given-names>SK</given-names></name>, <name name-style="western"><surname>Forbush</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Liang</surname><given-names>Y</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>Intraclonal competition limits the fate determination of regulatory T cells in the thymus</article-title>. <source>Nat Immunol</source> <volume>10</volume>: <fpage>610</fpage>â€“<lpage>7</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003102-Leung1"><label>23</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Leung</surname><given-names>MWL</given-names></name>, <name name-style="western"><surname>Shen</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Lafaille</surname><given-names>JJ</given-names></name> (<year>2009</year>) <article-title>TCR-dependent differentiation of thymic Foxp3+ cells is limited to small clonal sizes</article-title>. <source>J Exp Med</source> <volume>206</volume>: <fpage>2121</fpage>â€“<lpage>30</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003102-Moran1"><label>24</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Moran</surname><given-names>AE</given-names></name>, <name name-style="western"><surname>Holzapfel</surname><given-names>KL</given-names></name>, <name name-style="western"><surname>Xing</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Cunningham</surname><given-names>NR</given-names></name>, <name name-style="western"><surname>Maltzman</surname><given-names>JS</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>T cell receptor signal strength in Treg and iNKT cell development demonstrated by a novel fluorescent reporter mouse</article-title>. <source>J Exp Med</source> <volume>208</volume>: <fpage>1279</fpage>â€“<lpage>89</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003102-Eck1"><label>25</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Eck</surname><given-names>SC</given-names></name>, <name name-style="western"><surname>Zhu</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Pepper</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Bensinger</surname><given-names>SJ</given-names></name>, <name name-style="western"><surname>Freedman</surname><given-names>BD</given-names></name>, <etal>et al</etal>. (<year>2006</year>) <article-title>Developmental alterations in thymocyte sensitivity are actively regulated by MHC class II expression in the thymic medulla</article-title>. <source>J Immunol</source> <volume>176</volume>: <fpage>2229</fpage>â€“<lpage>37</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003102-Stephen1"><label>26</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Stephen</surname><given-names>TL</given-names></name>, <name name-style="western"><surname>Tikhonova</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Riberdy</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Laufer</surname><given-names>TM</given-names></name> (<year>2009</year>) <article-title>The activation threshold of CD4+ T cells is defined by TCR/peptide-MHC class II interactions in the thymic medulla</article-title>. <source>J Immunol</source> <volume>183</volume>: <fpage>5554</fpage>â€“<lpage>62</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003102-Azzam1"><label>27</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Azzam</surname><given-names>HS</given-names></name>, <name name-style="western"><surname>DeJarnette</surname><given-names>JB</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Emmons</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Park</surname><given-names>CS</given-names></name>, <etal>et al</etal>. (<year>2001</year>) <article-title>Fine tuning of TCR signaling by CD5</article-title>. <source>J Immunol</source> <volume>166</volume>: <fpage>5464</fpage>â€“<lpage>72</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003102-Saini1"><label>28</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Saini</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Sinclair</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Marshall</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Tolaini</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Sakaguchi</surname><given-names>S</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>Regulation of Zap70 expressionduring thymocyte development enables temporal separation of CD4 and CD8 repertoire selection at different signaling thresholds</article-title>. <source>Sci Signal</source> <volume>3</volume>: <fpage>ra23</fpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003102-Neilson1"><label>29</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Neilson</surname><given-names>JR</given-names></name>, <name name-style="western"><surname>Zheng</surname><given-names>GXY</given-names></name>, <name name-style="western"><surname>Burge</surname><given-names>CB</given-names></name>, <name name-style="western"><surname>Sharp</surname><given-names>PA</given-names></name> (<year>2007</year>) <article-title>Dynamic regulation of miRNA expression in ordered stages of cellular development</article-title>. <source>Genes Dev</source> <volume>21</volume>: <fpage>578</fpage>â€“<lpage>89</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003102-Li1"><label>30</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Li</surname><given-names>QJ</given-names></name>, <name name-style="western"><surname>Chau</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Ebert</surname><given-names>PJR</given-names></name>, <name name-style="western"><surname>Sylvester</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Min</surname><given-names>H</given-names></name>, <etal>et al</etal>. (<year>2007</year>) <article-title>miR-181a is an intrinsic modulator of T cell sensitivity and selection</article-title>. <source>Cell</source> <volume>129</volume>: <fpage>147</fpage>â€“<lpage>61</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003102-Davey1"><label>31</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Davey</surname><given-names>GM</given-names></name>, <name name-style="western"><surname>Schober</surname><given-names>SL</given-names></name>, <name name-style="western"><surname>Endrizzi</surname><given-names>BT</given-names></name>, <name name-style="western"><surname>Dutcher</surname><given-names>AK</given-names></name>, <name name-style="western"><surname>Jameson</surname><given-names>SC</given-names></name>, <etal>et al</etal>. (<year>1998</year>) <article-title>Preselection thymocytes are more sensitive to T cell receptor stimulation than mature T cells</article-title>. <source>J Exp Med</source> <volume>188</volume>: <fpage>1867</fpage>â€“<lpage>74</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003102-Chao1"><label>32</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chao</surname><given-names>DL</given-names></name>, <name name-style="western"><surname>Davenport</surname><given-names>MP</given-names></name>, <name name-style="western"><surname>Forrest</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Perelson</surname><given-names>AS</given-names></name> (<year>2005</year>) <article-title>The effects of thymic selection on the range of T cell cross-reactivity</article-title>. <source>Eur J Immunol</source> <volume>35</volume>: <fpage>3452</fpage>â€“<lpage>9</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003102-Kosmrlj1"><label>33</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kosmrlj</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Jha</surname><given-names>AK</given-names></name>, <name name-style="western"><surname>Huseby</surname><given-names>ES</given-names></name>, <name name-style="western"><surname>Kardar</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Chakraborty</surname><given-names>AK</given-names></name> (<year>2008</year>) <article-title>How the thymus designs antigen-specific and self-tolerant T cell receptor sequences</article-title>. <source>Proc Natl Acad Sci U S A</source> <volume>105</volume>: <fpage>16671</fpage>â€“<lpage>6</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003102-Detours1"><label>34</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Detours</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Perelson</surname><given-names>AS</given-names></name> (<year>1999</year>) <article-title>Explaining high alloreactivity as a quantitative consequence of affinity-driven thymocyte selection</article-title>. <source>Proc Natl Acad Sci U S A</source> <volume>96</volume>: <fpage>5153</fpage>â€“<lpage>8</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003102-Detours2"><label>35</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Detours</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Mehr</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Perelson</surname><given-names>AS</given-names></name> (<year>2000</year>) <article-title>Deriving quantitative constraints on T cell selection from data on the mature T cell repertoire</article-title>. <source>J Immunol</source> <volume>164</volume>: <fpage>121</fpage>â€“<lpage>8</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003102-Faro1"><label>36</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Faro</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Velasco</surname><given-names>S</given-names></name>, <name name-style="western"><surname>GonzÃ¡lez-FernÃ¡ndez</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Bandeira</surname><given-names>A</given-names></name> (<year>2004</year>) <article-title>The impact of thymic antigen diversity on the size of the selected T cell repertoire</article-title>. <source>J Immunol</source> <volume>172</volume>: <fpage>2247</fpage>â€“<lpage>55</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003102-SouzaeSilva1"><label>37</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Souza-e Silva</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Savino</surname><given-names>W</given-names></name>, <name name-style="western"><surname>FeijÃ³o</surname><given-names>RA</given-names></name>, <name name-style="western"><surname>Vasconcelos</surname><given-names>ATR</given-names></name> (<year>2009</year>) <article-title>A cellular automata-based mathematical model for thymocyte development</article-title>. <source>PLoS One</source> <volume>4</volume>: <fpage>e8233</fpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003102-Kosmrlj2"><label>38</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kosmrlj</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Read</surname><given-names>EL</given-names></name>, <name name-style="western"><surname>Qi</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Allen</surname><given-names>TM</given-names></name>, <name name-style="western"><surname>Altfeld</surname><given-names>M</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>Effects of thymic selection of the T-cell repertoire on HLA class I-associated control of HIV infection</article-title>. <source>Nature</source> <volume>465</volume>: <fpage>350</fpage>â€“<lpage>4</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003102-Borghans1"><label>39</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Borghans</surname><given-names>JAM</given-names></name>, <name name-style="western"><surname>Noest</surname><given-names>AJ</given-names></name>, <name name-style="western"><surname>De Boer</surname><given-names>RJ</given-names></name> (<year>2003</year>) <article-title>Thymic selection does not limit the individual MHC diversity</article-title>. <source>Eur J Immunol</source> <volume>33</volume>: <fpage>3353</fpage>â€“<lpage>8</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003102-McKeithan1"><label>40</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>McKeithan</surname><given-names>TW</given-names></name> (<year>1995</year>) <article-title>Kinetic proofreading in T-cell receptor signal transduction</article-title>. <source>Proc Natl Acad Sci U S A</source> <volume>92</volume>: <fpage>5042</fpage>â€“<lpage>6</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003102-Germain1"><label>41</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Germain</surname><given-names>RN</given-names></name>, <name name-style="western"><surname>StefanovÃ¡</surname><given-names>I</given-names></name> (<year>1999</year>) <article-title>The dynamics of T cell receptor signaling: complex orchestration and the key roles of tempo and cooperation</article-title>. <source>Annu Rev Immunol</source> <volume>17</volume>: <fpage>467</fpage>â€“<lpage>522</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003102-Valitutti1"><label>42</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Valitutti</surname><given-names>S</given-names></name>, <name name-style="western"><surname>MÃ¼ller</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Dessing</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Lanzavecchia</surname><given-names>A</given-names></name> (<year>1996</year>) <article-title>Different responses are elicited in cytotoxic T lymphocytes by different levels of T cell receptor occupancy</article-title>. <source>J Exp Med</source> <volume>183</volume>: <fpage>1917</fpage>â€“<lpage>21</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003102-Rosette1"><label>43</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rosette</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Werlen</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Daniels</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Holman</surname><given-names>PO</given-names></name>, <name name-style="western"><surname>Alam</surname><given-names>SM</given-names></name>, <etal>et al</etal>. (<year>2001</year>) <article-title>The impact of duration versus extent of TCR occupancy on T cell activation: a revision of the kinetic proofreading model</article-title>. <source>Immunity</source> <volume>15</volume>: <fpage>59</fpage>â€“<lpage>70</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003102-Labrecque1"><label>44</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Labrecque</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Whitfield</surname><given-names>LS</given-names></name>, <name name-style="western"><surname>Obst</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Waltzinger</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Benoist</surname><given-names>C</given-names></name>, <etal>et al</etal>. (<year>2001</year>) <article-title>How much TCR does a T cell need?</article-title> <source>Immunity</source> <volume>15</volume>: <fpage>71</fpage>â€“<lpage>82</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003102-Stone1"><label>45</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Stone</surname><given-names>JD</given-names></name>, <name name-style="western"><surname>Chervin</surname><given-names>AS</given-names></name>, <name name-style="western"><surname>Kranz</surname><given-names>DM</given-names></name> (<year>2009</year>) <article-title>T-cell receptor binding affinities and kinetics: impact on T-cell activity and specificity</article-title>. <source>Immunology</source> <volume>126</volume>: <fpage>165</fpage>â€“<lpage>76</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003102-Prasad1"><label>46</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Prasad</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Zikherman</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Das</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Roose</surname><given-names>JP</given-names></name>, <name name-style="western"><surname>Weiss</surname><given-names>A</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>Origin of the sharp boundary that discriminates positive and negative selection of thymocytes</article-title>. <source>Proc Natl Acad Sci U S A</source> <volume>106</volume>: <fpage>528</fpage>â€“<lpage>33</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003102-AltanBonnet1"><label>47</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Altan-Bonnet</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Germain</surname><given-names>RN</given-names></name> (<year>2005</year>) <article-title>Modeling T cell antigen discrimination based on feedback control of digital ERK responses</article-title>. <source>PLoS Biol</source> <volume>3</volume>: <fpage>e356</fpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003102-Currie1"><label>48</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Currie</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Castro</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Lythe</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Palmer</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Molina-ParÃ­s</surname><given-names>C</given-names></name> (<year>2012</year>) <article-title>A stochastic T cell response criterion</article-title>. <source>J R Soc Interface</source> <volume>9</volume>: <fpage>2856</fpage>â€“<lpage>70</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003102-Govern1"><label>49</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Govern</surname><given-names>CC</given-names></name>, <name name-style="western"><surname>Paczosa</surname><given-names>MK</given-names></name>, <name name-style="western"><surname>Chakraborty</surname><given-names>AK</given-names></name>, <name name-style="western"><surname>Huseby</surname><given-names>ES</given-names></name> (<year>2010</year>) <article-title>Fast on-rates allow short dwell time ligands to activate T cells</article-title>. <source>Proc Natl Acad Sci U S A</source> <volume>107</volume>: <fpage>8724</fpage>â€“<lpage>9</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003102-Underhill1"><label>50</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Underhill</surname><given-names>DM</given-names></name>, <name name-style="western"><surname>Bassetti</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Rudensky</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Aderem</surname><given-names>A</given-names></name> (<year>1999</year>) <article-title>Dynamic interactions of macrophages with T cells during antigen presentation</article-title>. <source>J Exp Med</source> <volume>190</volume>: <fpage>1909</fpage>â€“<lpage>14</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003102-Friedl1"><label>51</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Friedl</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Gunzer</surname><given-names>M</given-names></name> (<year>2001</year>) <article-title>Interaction of T cells with APCs: the serial encounter model</article-title>. <source>Trends Immunol</source> <volume>22</volume>: <fpage>187</fpage>â€“<lpage>91</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003102-Gunzer1"><label>52</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gunzer</surname><given-names>M</given-names></name>, <name name-style="western"><surname>SchÃ¤fer</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Borgmann</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Grabbe</surname><given-names>S</given-names></name>, <name name-style="western"><surname>ZÃ¤nker</surname><given-names>KS</given-names></name>, <etal>et al</etal>. (<year>2000</year>) <article-title>Antigen presentation in extracellular matrix: interactions of T cells with dendritic cells are dynamic, short lived, and sequential</article-title>. <source>Immunity</source> <volume>13</volume>: <fpage>323</fpage>â€“<lpage>32</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003102-Mempel1"><label>53</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mempel</surname><given-names>TR</given-names></name>, <name name-style="western"><surname>Henrickson</surname><given-names>SE</given-names></name>, <name name-style="western"><surname>Von Andrian</surname><given-names>UH</given-names></name> (<year>2004</year>) <article-title>T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases</article-title>. <source>Nature</source> <volume>427</volume>: <fpage>154</fpage>â€“<lpage>9</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003102-Kawahata2"><label>54</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kawahata</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Misaki</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Yamauchi</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Tsunekawa</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Setoguchi</surname><given-names>K</given-names></name>, <etal>et al</etal>. (<year>2002</year>) <article-title>Generation of CD4(+)CD25(+) regulatory T cells from autoreactive T cells simultaneously with their negative selection in the thymus and from nonautoreactive T cells by endogenous TCR expression</article-title>. <source>J Immunol</source> <volume>168</volume>: <fpage>4399</fpage>â€“<lpage>405</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003102-Nadarajah1"><label>55</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Nadarajah</surname><given-names>S</given-names></name> (<year>2008</year>) <article-title>A review of results on sums of random variables</article-title>. <source>Acta Appl Math</source> <volume>103</volume>: <fpage>131</fpage>â€“<lpage>140</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003102-Fisher1"><label>56</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Fisher</surname><given-names>RA</given-names></name>, <name name-style="western"><surname>Tippet</surname><given-names>LHC</given-names></name> (<year>1928</year>) <article-title>Limiting forms of the frequency distribution of the largest or smallest member of a sample</article-title>. <source>Proc Cambridge Phil Soc</source> <volume>24</volume>: <fpage>180</fpage>â€“<lpage>190</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003102-Gnedenko1"><label>57</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gnedenko</surname><given-names>PB</given-names></name> (<year>1943</year>) <article-title>Sur la distribution limite du terme maximum d'une serie aleatoire</article-title>. <source>Annals of Mathematics</source> <volume>44</volume>: <fpage>423</fpage>â€“<lpage>453</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003102-Obst1"><label>58</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Obst</surname><given-names>R</given-names></name>, <name name-style="western"><surname>van Santen</surname><given-names>HM</given-names></name>, <name name-style="western"><surname>Mathis</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Benoist</surname><given-names>C</given-names></name> (<year>2005</year>) <article-title>Antigen persistence is required throughout the expansion phase of a CD4(+) T cell response</article-title>. <source>J Exp Med</source> <volume>201</volume>: <fpage>1555</fpage>â€“<lpage>65</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003102-LeBorgne1"><label>59</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Le Borgne</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Ladi</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Dzhagalov</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Herzmark</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Liao</surname><given-names>YF</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>The impact of negative selection on thymocyte migration in the medulla</article-title>. <source>Nat Immunol</source> <volume>10</volume>: <fpage>823</fpage>â€“<lpage>30</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003102-Irvine1"><label>60</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Irvine</surname><given-names>DJ</given-names></name>, <name name-style="western"><surname>Purbhoo</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Krogsgaard</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Davis</surname><given-names>MM</given-names></name> (<year>2002</year>) <article-title>Direct observation of ligand recognition by T cells</article-title>. <source>Nature</source> <volume>419</volume>: <fpage>845</fpage>â€“<lpage>9</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003102-Brower1"><label>61</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Brower</surname><given-names>RC</given-names></name>, <name name-style="western"><surname>England</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Takeshita</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Kozlowski</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Margulies</surname><given-names>DH</given-names></name>, <etal>et al</etal>. (<year>1994</year>) <article-title>Minimal requirements for peptide mediated activation of CD8+ CTL</article-title>. <source>Mol Immunol</source> <volume>31</volume>: <fpage>1285</fpage>â€“<lpage>93</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003102-Naeher1"><label>62</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Naeher</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Daniels</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Hausmann</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Guillaume</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Luescher</surname><given-names>I</given-names></name>, <etal>et al</etal>. (<year>2007</year>) <article-title>A constant affinity threshold for T cell tolerance</article-title>. <source>J Exp Med</source> <volume>204</volume>: <fpage>2553</fpage>â€“<lpage>9</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003102-Hogquist1"><label>63</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hogquist</surname><given-names>KA</given-names></name>, <name name-style="western"><surname>Jameson</surname><given-names>SC</given-names></name>, <name name-style="western"><surname>Heath</surname><given-names>WR</given-names></name>, <name name-style="western"><surname>Howard</surname><given-names>JL</given-names></name>, <name name-style="western"><surname>Bevan</surname><given-names>MJ</given-names></name>, <etal>et al</etal>. (<year>1994</year>) <article-title>T cell receptor antagonist peptides induce positive selection</article-title>. <source>Cell</source> <volume>76</volume>: <fpage>17</fpage>â€“<lpage>27</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003102-Liu1"><label>64</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Liu</surname><given-names>CP</given-names></name>, <name name-style="western"><surname>Crawford</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Marrack</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Kappler</surname><given-names>J</given-names></name> (<year>1998</year>) <article-title>T cell positive selection by a high density, low affinity ligand</article-title>. <source>Proc Natl Acad Sci U S A</source> <volume>95</volume>: <fpage>4522</fpage>â€“<lpage>6</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003102-NikoliZugi1"><label>65</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>NikoliÄ‡-ZugiÄ‡</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Bevan</surname><given-names>MJ</given-names></name> (<year>1990</year>) <article-title>Role of self-peptides in positively selecting the T-cell repertoire</article-title>. <source>Nature</source> <volume>344</volume>: <fpage>65</fpage>â€“<lpage>7</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003102-Lio1"><label>66</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lio</surname><given-names>CWJ</given-names></name>, <name name-style="western"><surname>Hsieh</surname><given-names>CS</given-names></name> (<year>2008</year>) <article-title>A two-step process for thymic regulatory T cell development</article-title>. <source>Immunity</source> <volume>28</volume>: <fpage>100</fpage>â€“<lpage>11</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003102-Burchill1"><label>67</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Burchill</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Vang</surname><given-names>KB</given-names></name>, <name name-style="western"><surname>Moon</surname><given-names>JJ</given-names></name>, <name name-style="western"><surname>Chu</surname><given-names>HH</given-names></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>Linked T cell receptor and cytokine signaling govern the development of the regulatory T cell repertoire</article-title>. <source>Immunity</source> <volume>28</volume>: <fpage>112</fpage>â€“<lpage>21</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003102-Cheng1"><label>68</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cheng</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Yu</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Dee</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Malek</surname><given-names>TR</given-names></name> (<year>2013</year>) <article-title>IL-2R signaling is essential for functional maturation of regulatory T cells during thymic development</article-title>. <source>J Immunol</source> <volume>190</volume>: <fpage>1567</fpage>â€“<lpage>75</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003102-Nishizuka1"><label>69</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Nishizuka</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Sakakura</surname><given-names>T</given-names></name> (<year>1969</year>) <article-title>Thymus and reproduction: sex-linked dysgenesia of the gonad after neonatal thymectomy in mice</article-title>. <source>Science</source> <volume>166</volume>: <fpage>753</fpage>â€“<lpage>5</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003102-Asano1"><label>70</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Asano</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Toda</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Sakaguchi</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Sakaguchi</surname><given-names>S</given-names></name> (<year>1996</year>) <article-title>Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation</article-title>. <source>J Exp Med</source> <volume>184</volume>: <fpage>387</fpage>â€“<lpage>96</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003102-Fontenot1"><label>71</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Fontenot</surname><given-names>JD</given-names></name>, <name name-style="western"><surname>Dooley</surname><given-names>JL</given-names></name>, <name name-style="western"><surname>Farr</surname><given-names>AG</given-names></name>, <name name-style="western"><surname>Rudensky</surname><given-names>AY</given-names></name> (<year>2005</year>) <article-title>Developmental regulation of Foxp3 expression during ontogeny</article-title>. <source>J Exp Med</source> <volume>202</volume>: <fpage>901</fpage>â€“<lpage>6</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003102-Lee2"><label>72</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lee</surname><given-names>HM</given-names></name>, <name name-style="western"><surname>Hsieh</surname><given-names>CS</given-names></name> (<year>2009</year>) <article-title>Rare development of Foxp3+ thymocytes in the CD4+CD8+ subset</article-title>. <source>J Immunol</source> <volume>183</volume>: <fpage>2261</fpage>â€“<lpage>6</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003102-Cowan1"><label>73</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cowan</surname><given-names>JE</given-names></name>, <name name-style="western"><surname>Parnell</surname><given-names>SM</given-names></name>, <name name-style="western"><surname>Nakamura</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Caamano</surname><given-names>JH</given-names></name>, <name name-style="western"><surname>Lane</surname><given-names>PJL</given-names></name>, <etal>et al</etal>. (<year>2013</year>) <article-title>The thymic medulla is required for Foxp3+ regulatory but not conventional CD4+ thymocyte development</article-title>. <source>J Exp Med</source> <volume>210</volume>: <fpage>675</fpage>â€“<lpage>81</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003102-Nakayama1"><label>74</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Nakayama</surname><given-names>T</given-names></name>, <name name-style="western"><surname>June</surname><given-names>CH</given-names></name>, <name name-style="western"><surname>Munitz</surname><given-names>TI</given-names></name>, <name name-style="western"><surname>Sheard</surname><given-names>M</given-names></name>, <name name-style="western"><surname>McCarthy</surname><given-names>SA</given-names></name>, <etal>et al</etal>. (<year>1990</year>) <article-title>Inhibition of T cell receptor expression and function in immature CD4+CD8+ cells by CD4</article-title>. <source>Science</source> <volume>249</volume>: <fpage>1558</fpage>â€“<lpage>61</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003102-Lorenz1"><label>75</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lorenz</surname><given-names>RG</given-names></name>, <name name-style="western"><surname>Allen</surname><given-names>PM</given-names></name> (<year>1989</year>) <article-title>Thymic cortical epithelial cells lack full capacity for antigen presentation</article-title>. <source>Nature</source> <volume>340</volume>: <fpage>557</fpage>â€“<lpage>9</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003102-Mizuochi1"><label>76</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mizuochi</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Kasai</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Kokuho</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Kakiuchi</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Hirokawa</surname><given-names>K</given-names></name> (<year>1992</year>) <article-title>Medullary but not cortical thymic epithelial cells present soluble antigens to helper T cells</article-title>. <source>J Exp Med</source> <volume>175</volume>: <fpage>1601</fpage>â€“<lpage>5</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003102-Gray1"><label>77</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gray</surname><given-names>DHD</given-names></name>, <name name-style="western"><surname>Seach</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Ueno</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Milton</surname><given-names>MK</given-names></name>, <name name-style="western"><surname>Liston</surname><given-names>A</given-names></name>, <etal>et al</etal>. (<year>2006</year>) <article-title>Developmental kinetics, turnover, and stimulatory capacity of thymic epithelial cells</article-title>. <source>Blood</source> <volume>108</volume>: <fpage>3777</fpage>â€“<lpage>85</lpage>.</mixed-citation>
</ref>
</ref-list></back>
</article>